SEC Info - Iovance Biotherapeutics, Inc. - ‘10-K’ for 12/31/19

SEC Info℠

Home

My Interests

Help

Please Sign In

Iovance Biotherapeutics, Inc. – ‘10-K’ for 12/31/19 – ‘JSON’

On: Tuesday, 2/25/20, at 5:11pm ET · For: 12/31/19 · Accession #: 1104659-20-24830 · File #: 1-36860

Previous ‘10-K’: ‘10-K’ on 2/28/19 for 12/31/18 · Next: ‘10-K’ on 2/25/21 for 12/31/20 · Latest: ‘10-K’ on 2/28/24 for 12/31/23 · 10 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/25/20  Iovance Biotherapeutics, Inc.     10-K       12/31/19   88:11M                                    Toppan Merrill/FA

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.90M 
 2: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     53K 
 7: EX-10.10    Material Contract                                   HTML     62K 
 8: EX-10.11    Material Contract                                   HTML     62K 
 3: EX-10.4     Material Contract                                   HTML     51K 
 4: EX-10.5     Material Contract                                   HTML     52K 
 5: EX-10.7     Material Contract                                   HTML     53K 
 6: EX-10.8     Material Contract                                   HTML     51K 
 9: EX-21.1     Subsidiaries List                                   HTML     23K 
10: EX-23.1     Consent of Experts or Counsel                       HTML     28K 
11: EX-31.1     Certification -- §302 - SOA'02                      HTML     31K 
12: EX-31.2     Certification -- §302 - SOA'02                      HTML     31K 
13: EX-32.1     Certification -- §906 - SOA'02                      HTML     27K 
14: EX-32.2     Certification -- §906 - SOA'02                      HTML     27K 
68: R1          Document And Entity Information                     HTML     85K 
27: R2          Condensed Consolidated Balance Sheets               HTML    103K 
48: R3          Condensed Consolidated Balance Sheets               HTML     49K 
                (Parenthetical)                                                  
76: R4          Condensed Consolidated Statements of Operations     HTML     48K 
66: R5          Condensed Consolidated Statements of Comprehensive  HTML     37K 
                Loss                                                             
25: R6          Condensed Consolidated Statements of Stockholders'  HTML    104K 
                Equity                                                           
46: R7          Condensed Consolidated Statements of Cash Flows     HTML    104K 
78: R8          General Organization and Business                   HTML     34K 
63: R9          Summary of Significant Accounting Practices         HTML    169K 
21: R10         Cash and Cash Equivalents, and Short-Term           HTML    103K 
                Investments                                                      
41: R11         Balance Sheet Components                            HTML     61K 
73: R12         Stockholders' Equity                                HTML     74K 
61: R13         Stock Based Compensation                            HTML    169K 
22: R14         Employee Benefit Plan                               HTML     29K 
42: R15         Income Taxes                                        HTML    118K 
74: R16         Licenses and Agreements                             HTML     47K 
62: R17         Leases                                              HTML     97K 
20: R18         Legal Proceedings                                   HTML     52K 
43: R19         Quarterly Unaudited Results                         HTML     65K 
85: R20         Related Party Transactions                          HTML     30K 
56: R21         Summary of Significant Accounting Practices         HTML    222K 
                (Policies)                                                       
33: R22         Summary of Significant Accounting Practices         HTML    137K 
                (Tables)                                                         
39: R23         Cash and Cash Equivalents, and Short-Term           HTML    103K 
                Investments (Tables)                                             
86: R24         Balance Sheet Components (Tables)                   HTML     62K 
57: R25         Stockholders' Equity (Tables)                       HTML     64K 
34: R26         Stock Based Compensation (Tables)                   HTML    160K 
40: R27         Income Taxes (Tables)                               HTML    118K 
88: R28         Leases (Tables)                                     HTML     77K 
55: R29         Quarterly Unaudited Results (Tables)                HTML     64K 
59: R30         General Organization and Business (Details)         HTML     51K 
72: R31         SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES -       HTML     42K 
                Cash, Cash equivalents and Restricted Cash                       
                (Details)                                                        
45: R32         SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES -       HTML     39K 
                Useful lives, impairment (Details)                               
24: R33         SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Loss  HTML     36K 
                per share (Details)                                              
58: R34         SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Fair  HTML     37K 
                value (Details)                                                  
71: R35         SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES -       HTML     29K 
                Stock-based compensation expense (Details)                       
44: R36         SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES -       HTML     31K 
                Stock-based compensation by instrument (Details)                 
23: R37         SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES -       HTML     34K 
                Concentrations, etc. (Details)                                   
60: R38         SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES -       HTML     34K 
                Additional information (Details)                                 
69: R39         Cash and Cash Equivalents, and Short-Term           HTML     30K 
                Investments (Details)                                            
52: R40         Cash and Cash Equivalents, and Short-Term           HTML     31K 
                Investments - Short-term investments (Details)                   
84: R41         CASH AND CASH EQUIVALENTS, AND SHORT-TERM           HTML     39K 
                INVESTMENTS - Cost and fair value (Details)                      
37: R42         BALANCE SHEET COMPONENTS - Accrued liabilities      HTML     43K 
                (Details)                                                        
30: R43         BALANCE SHEET COMPONENTS - Other information        HTML     27K 
                (Details)                                                        
51: R44         BALANCE SHEET COMPONENTS - Additional information   HTML     41K 
                (Details)                                                        
83: R45         STOCKHOLDERS' EQUITY - Warrant activity (Details)   HTML     62K 
36: R46         STOCKHOLDERS' EQUITY - Additional Information       HTML     91K 
                (Details)                                                        
29: R47         STOCK BASED COMPENSATION - Stock Options (Details)  HTML     75K 
53: R48         STOCK BASED COMPENSATION - Assumptions (Details)    HTML     38K 
82: R49         STOCK BASED COMPENSATION - Exercise price           HTML     94K 
                (Details)                                                        
75: R50         STOCK BASED COMPENSATION - Additional information   HTML    107K 
                (Details)                                                        
65: R51         Employee Benefit Plan (Details)                     HTML     27K 
26: R52         Income Taxes (Details)                              HTML     54K 
47: R53         Income Taxes - Rate reconciliation (Details)        HTML     47K 
77: R54         INCOME TAXES - Expense components (Details)         HTML     46K 
67: R55         INCOME TAXES - Unrecognized benefits (Details)      HTML     32K 
28: R56         INCOME TAXES - Other information (Details)          HTML     40K 
49: R57         Licenses and Agreements (Details)                   HTML     82K 
79: R58         LEASES - Company's right-of-use asset and lease     HTML     34K 
                liabilities (Details)                                            
64: R59         LEASES - components of lease expenses (Details)     HTML     34K 
31: R60         LEASES - maturities of the Company's operating      HTML     50K 
                lease liabilities (Details)                                      
38: R61         LEASES - Additional information (Details)           HTML    150K 
81: R62         Legal Proceedings (Details)                         HTML     85K 
50: R63         Quarterly Unaudited Results (Details)               HTML     37K 
32: R64         Related Party Transactions (Details)                HTML     43K 
54: XML         IDEA XML File -- Filing Summary                      XML    147K 
80: XML         XBRL Instance -- iova-20191231x10kab9a30_htm         XML   2.60M 
35: EXCEL       IDEA Workbook of Financial Reports                  XLSX    100K 
16: EX-101.CAL  XBRL Calculations -- iova-20191231_cal               XML    148K 
17: EX-101.DEF  XBRL Definitions -- iova-20191231_def                XML    619K 
18: EX-101.LAB  XBRL Labels -- iova-20191231_lab                     XML   1.13M 
19: EX-101.PRE  XBRL Presentations -- iova-20191231_pre              XML    970K 
15: EX-101.SCH  XBRL Schema -- iova-20191231                         XSD    172K 
87: JSON        XBRL Instance as JSON Data -- MetaLinks              328±   505K 
70: ZIP         XBRL Zipped Folder -- 0001104659-20-024830-xbrl      Zip    656K

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

{
"instance":  {
    "iova-20191231x10kab9a30.htm":  {
        "axisCustom":  0,
        "axisStandard":  27,
        "contextCount":  291,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "iova-20191231_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "iova-20191231_def.xml"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
                    "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "iova-20191231x10kab9a30.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "iova-20191231_lab.xml"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml",
                    "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "iova-20191231_pre.xml"
                    ]
                },
            "referenceLink":  {
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
                    "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "iova-20191231.xsd"
                    ],
                "remote":  [
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
                    "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
                    "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
                    "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
                    "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
                    "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
                    ]
                }
            },
        "elementCount":  528,
        "entityCount":  1,
        "hidden":  {
            "http://fasb.org/us-gaap/2019-01-31":  51,
            "http://xbrl.sec.gov/dei/2019-01-31":  5,
            "total":  56
            },
        "keyCustom":  59,
        "keyStandard":  339,
        "memberCustom":  42,
        "memberStandard":  42,
        "nsprefix":  "iova",
        "nsuri":  "http://lbio.com/20191231",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "00090 - Document - Document And Entity Information",
                "role":  "http://lbio.com/role/DocumentDocumentAndEntityInformation",
                "shortName":  "Document And Entity Information",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "10301 - Disclosure - CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS",
                "role":  "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestments",
                "shortName":  "CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "10401 - Disclosure - BALANCE SHEET COMPONENTS",
                "role":  "http://lbio.com/role/DisclosureBalanceSheetComponents",
                "shortName":  "BALANCE SHEET COMPONENTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "10501 - Disclosure - STOCKHOLDERS' EQUITY",
                "role":  "http://lbio.com/role/DisclosureStockholdersEquity",
                "shortName":  "STOCKHOLDERS' EQUITY",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "10601 - Disclosure - STOCK BASED COMPENSATION",
                "role":  "http://lbio.com/role/DisclosureStockBasedCompensation",
                "shortName":  "STOCK BASED COMPENSATION",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "10701 - Disclosure - EMPLOYEE BENEFIT PLAN",
                "role":  "http://lbio.com/role/DisclosureEmployeeBenefitPlan",
                "shortName":  "EMPLOYEE BENEFIT PLAN",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "10801 - Disclosure - INCOME TAXES",
                "role":  "http://lbio.com/role/DisclosureIncomeTaxes",
                "shortName":  "INCOME TAXES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "iova:LicensesAndAgreementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "10901 - Disclosure - LICENSES AND AGREEMENTS",
                "role":  "http://lbio.com/role/DisclosureLicensesAndAgreements",
                "shortName":  "LICENSES AND AGREEMENTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "iova:LicensesAndAgreementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "11001 - Disclosure - LEASES",
                "role":  "http://lbio.com/role/DisclosureLeases",
                "shortName":  "LEASES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LossContingencyDisclosures",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "11101 - Disclosure - LEGAL PROCEEDINGS",
                "role":  "http://lbio.com/role/DisclosureLegalProceedings",
                "shortName":  "LEGAL PROCEEDINGS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LossContingencyDisclosures",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:QuarterlyFinancialInformationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "11201 - Disclosure - QUARTERLY UNAUDITED RESULTS",
                "role":  "http://lbio.com/role/DisclosureQuarterlyUnauditedResults",
                "shortName":  "QUARTERLY UNAUDITED RESULTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:QuarterlyFinancialInformationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00100 - Statement - Condensed Consolidated Balance Sheets",
                "role":  "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets",
                "shortName":  "Condensed Consolidated Balance Sheets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "11301 - Disclosure - RELATED PARTY TRANSACTIONS",
                "role":  "http://lbio.com/role/DisclosureRelatedPartyTransactions",
                "shortName":  "RELATED PARTY TRANSACTIONS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Policies)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "iova:RestrictedCashPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "iova:ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Tables)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesTables",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "iova:RestrictedCashPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "iova:ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "30303 - Disclosure - CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS (Tables)",
                "role":  "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsTables",
                "shortName":  "CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "30403 - Disclosure - BALANCE SHEET COMPONENTS (Tables)",
                "role":  "http://lbio.com/role/DisclosureBalanceSheetComponentsTables",
                "shortName":  "BALANCE SHEET COMPONENTS (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "30503 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
                "role":  "http://lbio.com/role/DisclosureStockholdersEquityTables",
                "shortName":  "STOCKHOLDERS' EQUITY (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "30603 - Disclosure - STOCK BASED COMPENSATION (Tables)",
                "role":  "http://lbio.com/role/DisclosureStockBasedCompensationTables",
                "shortName":  "STOCK BASED COMPENSATION (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "30903 - Disclosure - INCOME TAXES (Tables)",
                "role":  "http://lbio.com/role/DisclosureIncomeTaxesTables",
                "shortName":  "INCOME TAXES (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "iova:SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "31003 - Disclosure - LEASES (Tables)",
                "role":  "http://lbio.com/role/DisclosureLeasesTables",
                "shortName":  "LEASES (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "iova:SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:QuarterlyFinancialInformationTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "31203 - Disclosure - QUARTERLY UNAUDITED RESULTS (Tables)",
                "role":  "http://lbio.com/role/DisclosureQuarterlyUnauditedResultsTables",
                "shortName":  "QUARTERLY UNAUDITED RESULTS (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:QuarterlyFinancialInformationTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
                "role":  "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
                "shortName":  "Condensed Consolidated Balance Sheets (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:CommonStockSharesIssued",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    }
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
                        "us-gaap:QuarterlyFinancialInformationTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_10_1_2019_To_12_31_2019_tkSfSRpEIU20mDQsY_6q0g",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40101 - Disclosure - GENERAL ORGANIZATION AND BUSINESS (Details)",
                "role":  "http://lbio.com/role/DisclosureGeneralOrganizationAndBusinessDetails",
                "shortName":  "GENERAL ORGANIZATION AND BUSINESS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "iova:RestrictedCashPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SecurityDeposit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Cash, Cash equivalents and Restricted Cash (Details)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Cash, Cash equivalents and Restricted Cash (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "iova:RestrictedCashPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SecurityDeposit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "iova:ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock",
                        "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_OiO09iBtAUWGpfB3KUZa4Q",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentUsefulLife",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Useful lives, impairment (Details)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Useful lives, impairment (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "iova:ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock",
                        "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember_OiO09iBtAUWGpfB3KUZa4Q",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentUsefulLife",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "us-gaap:EarningsPerSharePolicyTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Loss per share (Details)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Loss per share (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "us-gaap:EarningsPerSharePolicyTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_6m5hsj0rZ0W9LpEPzGzcQw",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AssetsFairValueDisclosure",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40204 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Fair value (Details)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Fair value (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_6m5hsj0rZ0W9LpEPzGzcQw",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AssetsFairValueDisclosure",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
                        "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40205 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Stock-based compensation expense (Details)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationExpenseDetails",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Stock-based compensation expense (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                        "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_Y5N9m2dLeUaQZuLi6hfKhg",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
                        "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40206 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Stock-based compensation by instrument (Details)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationByInstrumentDetails",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Stock-based compensation by instrument (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
                        "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_H85ffco630OlV4uCUcaxWQ",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:ConcentrationRiskCreditRisk",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "iova:NumberOfFinancialInstitutions",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_item_q5uMIgdCIk2aYVouXcGNSA",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40207 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Concentrations, etc. (Details)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Concentrations, etc. (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:ConcentrationRiskCreditRisk",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "iova:NumberOfFinancialInstitutions",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_item_q5uMIgdCIk2aYVouXcGNSA",
                    "xsiNil":  "false"
                    }
                },
            "R38":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeaseRightOfUseAsset",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40208 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Additional information (Details)",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES - Additional information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:SegmentReportingPolicyPolicyTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_segment_sM-Z5OXzNU6dQKEuX9HJ3A",
                    "xsiNil":  "false"
                    }
                },
            "R39":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40301 - Disclosure - CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS (Details)",
                "role":  "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsDetails",
                "shortName":  "CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
                        "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_K-CstEUF3UuUTQl8fJwOYA",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ResearchAndDevelopmentExpense",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00200 - Statement - Condensed Consolidated Statements of Operations",
                "role":  "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations",
                "shortName":  "Condensed Consolidated Statements of Operations",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:GeneralAndAdministrativeExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R40":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShortTermInvestments",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40302 - Disclosure - CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS - Short-term investments (Details)",
                "role":  "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsShortTermInvestmentsDetails",
                "shortName":  "CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS - Short-term investments (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
                        "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_us-gaap_FinancialInstrumentAxis_us-gaap_USTreasurySecuritiesMember_3xmTYNSiQ0apngvNkT0xzQ",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:ShortTermInvestments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R41":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
                        "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AvailableForSaleSecuritiesAmortizedCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40303 - Disclosure - CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS - Cost and fair value (Details)",
                "role":  "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails",
                "shortName":  "CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS - Cost and fair value (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
                        "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AvailableForSaleSecuritiesAmortizedCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R42":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AccruedEmployeeBenefitsCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40401 - Disclosure - BALANCE SHEET COMPONENTS - Accrued liabilities (Details)",
                "role":  "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails",
                "shortName":  "BALANCE SHEET COMPONENTS - Accrued liabilities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AccruedEmployeeBenefitsCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R43":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40402 - Disclosure - BALANCE SHEET COMPONENTS - Other information (Details)",
                "role":  "http://lbio.com/role/DisclosureBalanceSheetComponentsOtherInformationDetails",
                "shortName":  "BALANCE SHEET COMPONENTS - Other information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R44":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PropertyPlantAndEquipmentGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40403 - Disclosure - BALANCE SHEET COMPONENTS - Additional information (Details)",
                "role":  "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                "shortName":  "BALANCE SHEET COMPONENTS - Additional information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PropertyPlantAndEquipmentGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R45":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40501 - Disclosure - STOCKHOLDERS' EQUITY - Warrant activity (Details)",
                "role":  "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails",
                "shortName":  "STOCKHOLDERS' EQUITY - Warrant activity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2016_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_WarrantMember_9qsyrubZ0EKtKXnj-T5z_Q",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    }
                },
            "R46":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_16_2019_To_1_16_2019_QqDV6crUQ0C8GAAARseN0A",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40502 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)",
                "role":  "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                "shortName":  "STOCKHOLDERS' EQUITY - Additional Information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_16_2019_To_1_16_2019_QqDV6crUQ0C8GAAARseN0A",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    }
                },
            "R47":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40601 - Disclosure - STOCK BASED COMPENSATION - Stock Options (Details)",
                "role":  "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                "shortName":  "STOCK BASED COMPENSATION - Stock Options (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2016_us-gaap_OptionIndexedToIssuersEquityTypeAxis_us-gaap_EmployeeStockOptionMember_30ogHP6wB0SeTeTyWan5iQ",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    }
                },
            "R48":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "2",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_pure_5H665uwI5EGII0mblweHHw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40602 - Disclosure - STOCK BASED COMPENSATION - Assumptions (Details)",
                "role":  "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails",
                "shortName":  "STOCK BASED COMPENSATION - Assumptions (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "2",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_pure_5H665uwI5EGII0mblweHHw",
                    "xsiNil":  "false"
                    }
                },
            "R49":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_shares_pv5Xji0EM0CB_OEYtiC98g",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40603 - Disclosure - STOCK BASED COMPENSATION - Exercise price (Details)",
                "role":  "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails",
                "shortName":  "STOCK BASED COMPENSATION - Exercise price (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_iova_RangeOfExercisePricesOneMember_kF_ITMGIvUu0kwuiutW_Xw",
                    "decimals":  "2",
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Divide_USD_shares_oUZQ5UuEKEqGtGIx-qR8Kw",
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00300 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
                "role":  "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss",
                "shortName":  "Condensed Consolidated Statements of Comprehensive Loss",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:ComprehensiveIncomeNetOfTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R50":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40604 - Disclosure - STOCK BASED COMPENSATION - Additional information (Details)",
                "role":  "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                "shortName":  "STOCK BASED COMPENSATION - Additional information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R51":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DefinedContributionPlanCostRecognized",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40701 - Disclosure - EMPLOYEE BENEFIT PLAN (Details)",
                "role":  "http://lbio.com/role/DisclosureEmployeeBenefitPlanDetails",
                "shortName":  "EMPLOYEE BENEFIT PLAN (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DefinedContributionPlanCostRecognized",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R52":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40801 - Disclosure - INCOME TAXES (Details)",
                "role":  "http://lbio.com/role/DisclosureIncomeTaxesDetails",
                "shortName":  "INCOME TAXES (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R53":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "2",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_pure_5H665uwI5EGII0mblweHHw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40802 - Disclosure - INCOME TAXES - Rate reconciliation (Details)",
                "role":  "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails",
                "shortName":  "INCOME TAXES - Rate reconciliation (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "2",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_pure_5H665uwI5EGII0mblweHHw",
                    "xsiNil":  "false"
                    }
                },
            "R54":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CurrentFederalTaxExpenseBenefit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40803 - Disclosure - INCOME TAXES - Expense components (Details)",
                "role":  "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails",
                "shortName":  "INCOME TAXES - Expense components (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CurrentFederalTaxExpenseBenefit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R55":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2018_KXTqnRFVTkuiVH77LE-xVA",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:UnrecognizedTaxBenefits",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40804 - Disclosure - INCOME TAXES - Unrecognized benefits (Details)",
                "role":  "http://lbio.com/role/DisclosureIncomeTaxesUnrecognizedBenefitsDetails",
                "shortName":  "INCOME TAXES - Unrecognized benefits (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2016_kQKpSGQ9aEatiTxancefPw",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:UnrecognizedTaxBenefits",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R56":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "iova:OperatingLossCarryForwardsHavingDefiniteExpireLifeValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40805 - Disclosure - INCOME TAXES - Other information (Details)",
                "role":  "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails",
                "shortName":  "INCOME TAXES - Other information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "iova:OperatingLossCarryForwardsHavingDefiniteExpireLifeValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R57":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ResearchAndDevelopmentExpense",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "40901 - Disclosure - LICENSES AND AGREEMENTS (Details)",
                "role":  "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                "shortName":  "LICENSES AND AGREEMENTS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_iova_StrategicAllianceAgreementMember_3QLuT0pNKUKQvsSLT5pZmw",
                    "decimals":  "-5",
                    "lang":  null,
                    "name":  "us-gaap:ResearchAndDevelopmentExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R58":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeaseRightOfUseAsset",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "41001 - Disclosure - LEASES - Company's right-of-use asset and lease liabilities (Details)",
                "role":  "http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails",
                "shortName":  "LEASES - Company's right-of-use asset and lease liabilities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R59":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeaseCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "41002 - Disclosure - LEASES - components of lease expenses (Details)",
                "role":  "http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails",
                "shortName":  "LEASES - components of lease expenses (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeaseCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2016_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_aWJMu2tD9kGTn0GicnsLsw",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00400 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
                "role":  "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity",
                "shortName":  "Condensed Consolidated Statements of Stockholders' Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2016_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesBPreferredStockMember_aWJMu2tD9kGTn0GicnsLsw",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R60":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "41003 - Disclosure - LEASES - maturities of the Company's operating lease liabilities (Details)",
                "role":  "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails",
                "shortName":  "LEASES - maturities of the Company's operating lease liabilities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R61":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseTermOfContract",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "41004 - Disclosure - LEASES - Additional information (Details)",
                "role":  "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                "shortName":  "LEASES - Additional information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "As_Of_12_31_2019_F9_vB-_Os0SyWKU-mMNPcQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseTermOfContract",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R62":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_6_3_2016_To_6_3_2016_SWQO9VkGZkKvxaleJCMDYg",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:LossContingencyDamagesSoughtValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "41101 - Disclosure - LEGAL PROCEEDINGS (Details)",
                "role":  "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                "shortName":  "LEGAL PROCEEDINGS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_6_3_2016_To_6_3_2016_SWQO9VkGZkKvxaleJCMDYg",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:LossContingencyDamagesSoughtValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R63":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
                        "us-gaap:QuarterlyFinancialInformationTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_10_1_2019_To_12_31_2019_tkSfSRpEIU20mDQsY_6q0g",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "41201 - Disclosure - QUARTERLY UNAUDITED RESULTS (Details)",
                "role":  "http://lbio.com/role/DisclosureQuarterlyUnauditedResultsDetails",
                "shortName":  "QUARTERLY UNAUDITED RESULTS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
                        "us-gaap:QuarterlyFinancialInformationTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_10_1_2019_To_12_31_2019_tkSfSRpEIU20mDQsY_6q0g",
                    "decimals":  "2",
                    "lang":  null,
                    "name":  "us-gaap:EarningsPerShareBasicAndDiluted",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Divide_USD_shares_oUZQ5UuEKEqGtGIx-qR8Kw",
                    "xsiNil":  "false"
                    }
                },
            "R64":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "iova:PaymentsForLegalServices",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "41301 - Disclosure - RELATED PARTY TRANSACTIONS (Details)",
                "role":  "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails",
                "shortName":  "RELATED PARTY TRANSACTIONS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "iova:PaymentsForLegalServices",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00500 - Statement - Condensed Consolidated Statements of Cash Flows",
                "role":  "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
                "shortName":  "Condensed Consolidated Statements of Cash Flows",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "iova:NonCashLeaseExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Unit_Standard_USD_ouFAG2xp40iipjAMXYREKw",
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "10101 - Disclosure - GENERAL ORGANIZATION AND BUSINESS",
                "role":  "http://lbio.com/role/DisclosureGeneralOrganizationAndBusiness",
                "shortName":  "GENERAL ORGANIZATION AND BUSINESS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES",
                "role":  "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPractices",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "iova-20191231x10kab9a30.htm",
                    "contextRef":  "Duration_1_1_2019_To_12_31_2019_pqRi7rJJu0WkerXSWSI_GQ",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                }
            },
        "segmentCount":  87,
        "tag":  {
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentAnnualReport":  {
                "auth_ref":  [
                    "r341"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an annual report.",
                            "label":  "Document Annual Report"
                            }
                        }
                    },
                "localname":  "DocumentAnnualReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.   1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in CCYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The end date of the period reflected on the cover page if a periodic report.  For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date.  The format of the date is CCYY-MM-DD.",
                            "label":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r340"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r343"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityPublicFloat":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
                            "label":  "Entity Public Float"
                            }
                        }
                    },
                "localname":  "EntityPublicFloat",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_EntityVoluntaryFilers":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
                            "label":  "Entity Voluntary Filers"
                            }
                        }
                    },
                "localname":  "EntityVoluntaryFilers",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityWellKnownSeasonedIssuer":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
                            "label":  "Entity Well-known Seasoned Issuer"
                            }
                        }
                    },
                "localname":  "EntityWellKnownSeasonedIssuer",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r338"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r339"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "iova_AccountingPoliciesLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES.",
                            "terseLabel":  "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesLineItems",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "iova_AccountingPoliciesTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of information about  significant accounting policies.",
                            "label":  "Accounting Policies [Table]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesTable",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "iova_AdditionalAreaOfSpaceUnderAmendedLease":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of additional space to be taken under lease under Amended Lease.",
                            "label":  "Additional Area of Space Under Amended Lease",
                            "verboseLabel":  "Additional space of lease"
                            }
                        }
                    },
                "localname":  "AdditionalAreaOfSpaceUnderAmendedLease",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "decimalItemType"
                },
            "iova_AdditionalMilestonePayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of additional milestone payable.",
                            "label":  "Additional Milestone Payable",
                            "terseLabel":  "Additional milestone payable"
                            }
                        }
                    },
                "localname":  "AdditionalMilestonePayable",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_AggregateIntrinsicValueAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "n/a",
                            "label":  "Aggregate Intrinsic Value"
                            }
                        }
                    },
                "localname":  "AggregateIntrinsicValueAbstract",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "iova_AgreementTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "It represents the term of agreement.",
                            "label":  "Agreement Term",
                            "terseLabel":  "Agreement term"
                            }
                        }
                    },
                "localname":  "AgreementTerm",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "iova_AshCashEquivalentsAndShortTermInvestmentsAndRestrictedCashTotal":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Cash includes currency on hand as well as demand deposits with banks or financial institutions.  It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty.  Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates.  Generally, only investments with original maturities of three months or less qualify under that definition.  Original maturity means original maturity to the entity holding the investment.  For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents.  However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months.  Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
                            "label":  "ash, Cash Equivalents, and Short-term Investments, and Restricted Cash, Total",
                            "terseLabel":  "cash equivalents, short-term investments, and restricted cash"
                            }
                        }
                    },
                "localname":  "AshCashEquivalentsAndShortTermInvestmentsAndRestrictedCashTotal",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureGeneralOrganizationAndBusinessDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_AvailableForSaleSecuritiesAccumulatedAccretion":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of accumulated accretion on available for sale securities.",
                            "label":  "Available for Sale Securities Accumulated Accretion",
                            "verboseLabel":  "Accretion"
                            }
                        }
                    },
                "localname":  "AvailableForSaleSecuritiesAccumulatedAccretion",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_CancellationOfCommonSharesFromSettlementOfDisputeInShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cancellation shares from settlement of dispute.",
                            "label":  "Cancellation of common shares from settlement of dispute (In Shares)",
                            "terseLabel":  "Cancellation of common shares from settlement of dispute (In Shares)"
                            }
                        }
                    },
                "localname":  "CancellationOfCommonSharesFromSettlementOfDisputeInShares",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "iova_ClassActionSuitsAllegingViolationOfFederalSecuritiesLawsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to class action suits alleging violations of federal securities laws.",
                            "label":  "Class Action Suits Alleging Violation Of Federal Securities Laws [Member]",
                            "terseLabel":  "Class Action Suits Alleging Violation Of Federal Securities Laws"
                            }
                        }
                    },
                "localname":  "ClassActionSuitsAllegingViolationOfFederalSecuritiesLawsMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_ClinicalRelatedExpensesCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical and related services.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Clinical Related Expenses Current",
                            "terseLabel":  "Clinical related"
                            }
                        }
                    },
                "localname":  "ClinicalRelatedExpensesCurrent",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_CmoEmbeddedLeasesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Cmo Embedded Leases [Member]",
                            "terseLabel":  "CMO embedded leases"
                            }
                        }
                    },
                "localname":  "CmoEmbeddedLeasesMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_CommercialManufacturingFacilityAgreementForPhaseIBMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Representing information pertaining to commercial manufacturing facility agreement for Phase I-B.",
                            "label":  "Commercial Manufacturing Facility Agreement For Phase I B [Member]",
                            "terseLabel":  "Commercial Manufacturing Facility Agreement for Phase I-B"
                            }
                        }
                    },
                "localname":  "CommercialManufacturingFacilityAgreementForPhaseIBMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_CommercialManufacturingFacilityAgreementForPhaseIMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Representing information pertaining to commercial manufacturing facility agreement for Phase I-A.",
                            "label":  "Commercial Manufacturing Facility Agreement For Phase I [Member]",
                            "terseLabel":  "Commercial Manufacturing Facility Agreement for Phase I-A"
                            }
                        }
                    },
                "localname":  "CommercialManufacturingFacilityAgreementForPhaseIMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_CommercialManufacturingFacilityAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Representing information pertaining to commercial manufacturing facility agreement.",
                            "label":  "Commercial Manufacturing Facility Agreement [Member]",
                            "terseLabel":  "Commercial Manufacturing Facility Agreement"
                            }
                        }
                    },
                "localname":  "CommercialManufacturingFacilityAgreementMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_CommonStockIssuedFromPreferredStockConversion":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of Common stock issued from preferred stock conversion.",
                            "label":  "Common Stock Issued From Preferred Stock Conversion",
                            "terseLabel":  "Common stock issued from preferred stock conversion"
                            }
                        }
                    },
                "localname":  "CommonStockIssuedFromPreferredStockConversion",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_CommonStockIssuedFromPreferredStockConversionShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of Common stock issued from preferred stock conversion.",
                            "label":  "Common Stock Issued From Preferred Stock Conversion, Shares",
                            "terseLabel":  "Common stock issued from preferred stock conversion (in Shares)"
                            }
                        }
                    },
                "localname":  "CommonStockIssuedFromPreferredStockConversionShares",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "iova_CommonStockIssuedUponExerciseOfWarrantsAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of exchange transaction inducement costs capitalized during the period.",
                            "label":  "Common Stock Issued Upon Exercise Of Warrants Amount",
                            "verboseLabel":  "Common stock issued upon exercise of warrants"
                            }
                        }
                    },
                "localname":  "CommonStockIssuedUponExerciseOfWarrantsAmount",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_CommonStockIssuedUponExerciseOfWarrantsShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares issued upon exercise of warrant.",
                            "label":  "Common Stock Issued Upon Exercise Of Warrants Shares",
                            "verboseLabel":  "Common stock issued upon exercise of warrants (in Shares)"
                            }
                        }
                    },
                "localname":  "CommonStockIssuedUponExerciseOfWarrantsShares",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "iova_CommonStockRegisteredForResale":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of common shares which registered for resale.",
                            "label":  "Common Stock Registered For Resale",
                            "terseLabel":  "Common stock registered for resale"
                            }
                        }
                    },
                "localname":  "CommonStockRegisteredForResale",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "iova_ConsultingAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Consulting Agreement [Member]",
                            "terseLabel":  "Consulting Agreement"
                            }
                        }
                    },
                "localname":  "ConsultingAgreementMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_ConvertibleInstrumentsPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The accounting policy for all convertible instruments issued by the entity.",
                            "label":  "Convertible Instruments Policy [Text Block]",
                            "verboseLabel":  "Convertible Instruments"
                            }
                        }
                    },
                "localname":  "ConvertibleInstrumentsPolicyTextBlock",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "iova_ConvertiblePreferredStockNumberOfSharesOfCommonStockAvailableUponConversionTotal":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The total number of shares of common stock into which the convertible preferred stock may be converted, at balance sheet date.",
                            "label":  "Convertible Preferred Stock Number Of Shares Of Common Stock Available Upon Conversion, Total",
                            "terseLabel":  "Common stock available in conversion, shares"
                            }
                        }
                    },
                "localname":  "ConvertiblePreferredStockNumberOfSharesOfCommonStockAvailableUponConversionTotal",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "iova_ConvertiblePricePerShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The price per share at which the preferred stock of an entity is converted.",
                            "label":  "Convertible Price Per Shares",
                            "terseLabel":  "Convertible price per shares"
                            }
                        }
                    },
                "localname":  "ConvertiblePricePerShares",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "iova_CooperativeResearchAndDevelopmentAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Cooperative Research And Development Agreement [Member]",
                            "terseLabel":  "Cooperative Research and Development Agreement"
                            }
                        }
                    },
                "localname":  "CooperativeResearchAndDevelopmentAgreementMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_DeferredTaxAssetsDepreciationAndAmortization":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from depreciation and amortization.",
                            "label":  "Deferred Tax Assets Depreciation And Amortization",
                            "terseLabel":  "Depreciation and Amortization"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsDepreciationAndAmortization",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_DeferredTaxAssetsLeaseLiabilities":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.",
                            "label":  "Deferred Tax Assets, Lease Liabilities",
                            "terseLabel":  "Lease liabilities"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsLeaseLiabilities",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_DeferredTaxLiabilitiesDepreciationAndAmortization":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsLiabilitiesNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax liability attributable to taxable temporary differences depreciation and amortization.",
                            "label":  "Deferred Tax Liabilities, Depreciation And Amortization",
                            "negatedLabel":  "Depreciation and amortization"
                            }
                        }
                    },
                "localname":  "DeferredTaxLiabilitiesDepreciationAndAmortization",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_DocumentAndEntityInformationAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Document And Entity Information [Abstract]",
                            "label":  "Document And Entity Information [Abstract]"
                            }
                        }
                    },
                "localname":  "DocumentAndEntityInformationAbstract",
                "nsuri":  "http://lbio.com/20191231",
                "xbrltype":  "stringItemType"
                },
            "iova_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Represents the sum of Federal Statutory tax rate and State tax net of federal benefit.",
                            "label":  "Effective Income Tax Rate Reconciliation, Expected Rate Total 1",
                            "terseLabel":  "Effective Income Tax Rate Reconciliation Expected Rate Total"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationExpectedRateTotal1",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "iova_EquityIncentivePlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Equity Incentive Plan [Member]",
                            "terseLabel":  "Equity Incentive Plan"
                            }
                        }
                    },
                "localname":  "EquityIncentivePlanMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_FacilityLeasesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Facility Leases [Member]",
                            "terseLabel":  "Facility leases"
                            }
                        }
                    },
                "localname":  "FacilityLeasesMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_IncreaseDecreaseInOperatingLeaseLiabilities":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The Non cash increase decrease in operating lease liability as a result of lease modifications.",
                            "label":  "Increase (Decrease) in Operating Lease Liabilities",
                            "terseLabel":  "Increase in operating lease liability"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingLeaseLiabilities",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_IncreaseDecreaseInOperatingLeaseRightOfUseAsset":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of operating lease liabilities.",
                            "label":  "Increase Decrease in operating Lease Right of Use Asset",
                            "verboseLabel":  "Operating lease liabilities (Right-of-use assets)"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_IncreaseDecreaseInOperatingLeaseRightOfUseAssets":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The Non cash increase decrease in operating lease right of use asset as a result of lease modifications.",
                            "label":  "Increase (Decrease) in Operating Lease Right of Use Assets",
                            "terseLabel":  "Increase in operating lease right-of-use assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingLeaseRightOfUseAssets",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_IssuanceOfCommonStockUponConversionOfPreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Issuance Of Common Stock Upon Conversion Of Preferred Stock [Member]",
                            "terseLabel":  "Issuance Of Common Stock Upon Conversion Of Preferred Stock"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonStockUponConversionOfPreferredStockMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_LeaseExpirationTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Expiration term of the lease agreement.",
                            "label":  "Lease Expiration Term"
                            }
                        }
                    },
                "localname":  "LeaseExpirationTerm",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "iova_LeaseholdImprovementsPaidByLandlord":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Future cash outflow to pay for leasehold improvements that have occurred.",
                            "label":  "Leasehold Improvements Paid by Landlord",
                            "verboseLabel":  "Acquisitions of property and equipment included in accounts payable"
                            }
                        }
                    },
                "localname":  "LeaseholdImprovementsPaidByLandlord",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_LegalAndRelatedServicesCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for legal and related services.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Legal And Related Services Current",
                            "terseLabel":  "Legal and related services"
                            }
                        }
                    },
                "localname":  "LegalAndRelatedServicesCurrent",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_LicensesAndAgreementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "LICENSES AND AGREEMENTS"
                            }
                        }
                    },
                "localname":  "LicensesAndAgreementsAbstract",
                "nsuri":  "http://lbio.com/20191231",
                "xbrltype":  "stringItemType"
                },
            "iova_LicensesAndAgreementsDisclosureTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for licenses and agreements.",
                            "label":  "Licenses And Agreements Disclosure [Text Block]",
                            "terseLabel":  "LICENSES AND AGREEMENTS"
                            }
                        }
                    },
                "localname":  "LicensesAndAgreementsDisclosureTextBlock",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreements"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "iova_ManufacturingRelatedExpensesCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for manufacturing of the entity's goods and services.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Manufacturing Related Expenses Current",
                            "terseLabel":  "Manufacturing related"
                            }
                        }
                    },
                "localname":  "ManufacturingRelatedExpensesCurrent",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_ManufacturingSuitesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Manufacturing Suites [Member]",
                            "terseLabel":  "Manufacturing Suites"
                            }
                        }
                    },
                "localname":  "ManufacturingSuitesMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_MaximumOperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateAverageTenYearConsumerPriceIndex":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "\"The maximum percentage points added to the reference rate to compute the variable rate on the lessee's operating lease based on average ten-year consumer price index.",
                            "label":  "Maximum Operating Leases of Lessee, Contingent Rentals, Basis Spread on Variable Rate, Average Ten Year Consumer Price Index",
                            "terseLabel":  "Maximum annual increase in basis spread on variable rate (as a percent)"
                            }
                        }
                    },
                "localname":  "MaximumOperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateAverageTenYearConsumerPriceIndex",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "iova_MedimmuneAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "n/a",
                            "label":  "Medimmune Agreement [Member]",
                            "terseLabel":  "MedImmune"
                            }
                        }
                    },
                "localname":  "MedimmuneAgreementMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_MinimumOperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateAverageTenYearConsumerPriceIndex":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "\"The minimum percentage points added to the reference rate to compute the variable rate on the lessee's operating lease based on average ten-year consumer price index.",
                            "label":  "Minimum Operating Leases of Lessee, Contingent Rentals, Basis Spread on Variable Rate, Average Ten Year Consumer Price Index",
                            "terseLabel":  "Minimum annual increase in basis spread on variable rate (as a percent)"
                            }
                        }
                    },
                "localname":  "MinimumOperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateAverageTenYearConsumerPriceIndex",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "iova_MoffittLicenseAgreementOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Moffitt License Agreement One [Member]",
                            "terseLabel":  "Moffitt License Agreement One"
                            }
                        }
                    },
                "localname":  "MoffittLicenseAgreementOneMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_MoffittLicenseAgreementTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Moffitt License Agreement Two [Member]",
                            "terseLabel":  "Moffitt License Agreement Two"
                            }
                        }
                    },
                "localname":  "MoffittLicenseAgreementTwoMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_NewYorkLeaseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "New York Lease [Member]",
                            "terseLabel":  "New York Lease"
                            }
                        }
                    },
                "localname":  "NewYorkLeaseMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_NonCashLeaseExpense":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of Noncash lease expense.",
                            "label":  "Non Cash Lease Expense",
                            "terseLabel":  "Noncash lease expense"
                            }
                        }
                    },
                "localname":  "NonCashLeaseExpense",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_NotificationPeriodToTerminateAgreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The required notification period before the party may terminate the agreement.",
                            "label":  "Notification Period To Terminate Agreement"
                            }
                        }
                    },
                "localname":  "NotificationPeriodToTerminateAgreement",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "iova_NumberOfClinicalTrials":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of clinical trials conducted, or to be conducted, under the agreement.",
                            "label":  "Number Of Clinical Trials"
                            }
                        }
                    },
                "localname":  "NumberOfClinicalTrials",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "iova_NumberOfFinancialInstitutions":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of financial institutions at which the entity maintains balances.",
                            "label":  "Number Of Financial Institutions"
                            }
                        }
                    },
                "localname":  "NumberOfFinancialInstitutions",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "iova_NumberOfIndicationsUnderAgreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of indications covered under the agreement.",
                            "label":  "Number Of Indications Under Agreement"
                            }
                        }
                    },
                "localname":  "NumberOfIndicationsUnderAgreement",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "iova_NumberOfPhases":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of phases in leases.",
                            "label":  "Number of Phases",
                            "terseLabel":  "Number of phases"
                            }
                        }
                    },
                "localname":  "NumberOfPhases",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "iova_NumberOfShareOptionsOrShareUnitsExercisedDuringCurrentPeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Number of share options or share units exercised during the current period."
                            }
                        }
                    },
                "localname":  "NumberOfShareOptionsOrShareUnitsExercisedDuringCurrentPeriod",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "iova_NumberOfStatementsOfWork":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of statements of work under the agreement.",
                            "label":  "Number Of Statements Of Work"
                            }
                        }
                    },
                "localname":  "NumberOfStatementsOfWork",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "iova_NumberOfSuitesUnderAgreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of suites under the agreement.",
                            "label":  "Number Of Suites Under The Agreement"
                            }
                        }
                    },
                "localname":  "NumberOfSuitesUnderAgreement",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "iova_OfficeSpaceMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Office Space [Member]",
                            "terseLabel":  "Office Space"
                            }
                        }
                    },
                "localname":  "OfficeSpaceMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_OperatingLeaseLiabilityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Operating Lease Liability [Abstract]",
                            "verboseLabel":  "Operating lease liabilities"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityAbstract",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "iova_OperatingLeasePresentValueAdjustments":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetailsCalc2":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Operating lease present value adjustments.",
                            "label":  "Operating Lease Present Value Adjustments",
                            "verboseLabel":  "Less:  Present value adjustment"
                            }
                        }
                    },
                "localname":  "OperatingLeasePresentValueAdjustments",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_OperatingLossCarryForwardsHavingDefiniteExpireLifeValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Operating Loss Carry forwards Having Definite Expire life Value.",
                            "label":  "Operating Loss Carry forwards Having Definite Expire life Value"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryForwardsHavingDefiniteExpireLifeValue",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_OperatingLossCarryForwardsHavingIndefiniteExpireLifeValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Operating Loss Carry forwards Having Indefinite Expire life Value.",
                            "label":  "Operating Loss Carry forwards Having Indefinite Expire life Value"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryForwardsHavingIndefiniteExpireLifeValue",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_PaymentsForLegalServices":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of cash paid for the legal service during the period.",
                            "label":  "Payments for Legal Services"
                            }
                        }
                    },
                "localname":  "PaymentsForLegalServices",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_PaymentsForUpfrontLicensingFee":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This element represents the amount of cash outflow for the payment of upfront licensing fee.",
                            "label":  "Payments For Upfront Licensing Fee",
                            "terseLabel":  "Payments for upfront licensing fee"
                            }
                        }
                    },
                "localname":  "PaymentsForUpfrontLicensingFee",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_PeriodOfConsultingAgreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Term of consulting agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Period of Consulting Agreement",
                            "verboseLabel":  "Term of consulting agreement (in years)"
                            }
                        }
                    },
                "localname":  "PeriodOfConsultingAgreement",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "iova_PeriodOfSubstantialCompletionForPhaseI":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Period of Phase I-A substantial completion , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Term of Phase I-A"
                            }
                        }
                    },
                "localname":  "PeriodOfSubstantialCompletionForPhaseI",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "iova_PhiladelphiaOfficeLeaseForFirstYearMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Representing information pertaining to Philadelphia office lease for first year.",
                            "label":  "Philadelphia Office Lease For First Year [Member]",
                            "terseLabel":  "Philadelphia Office Lease for first year"
                            }
                        }
                    },
                "localname":  "PhiladelphiaOfficeLeaseForFirstYearMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_PhiladelphiaOfficeLeaseForNextThreeYearsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Representing information pertaining to Philadelphia office lease for next three years.",
                            "label":  "Philadelphia Office Lease For Next Three Years [Member]",
                            "terseLabel":  "Philadelphia Office Lease for next three Years"
                            }
                        }
                    },
                "localname":  "PhiladelphiaOfficeLeaseForNextThreeYearsMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_PriorWrittenNoticePeriodToLandlord":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Term of prior written notice period to landlord , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Prior Written Notice Period to Landlord",
                            "terseLabel":  "Prior written notice period (in months)"
                            }
                        }
                    },
                "localname":  "PriorWrittenNoticePeriodToLandlord",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "iova_ProceedsFromIssuanceOfCommonAndPreferredStock":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash inflow from the additional capital contribution to the entity.",
                            "label":  "Proceeds From The Issuance Of Common And Preferred Stock",
                            "terseLabel":  "Proceeds from the issuance of preferred stock and common stock, net"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonAndPreferredStock",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_ProceedsFromIssuanceOfCommonStockGross":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The gross cash inflow from the additional capital contribution to the entity.",
                            "label":  "Proceeds From Issuance Of Common Stock Gross",
                            "terseLabel":  "Gross proceeds from issuance of common stock"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonStockGross",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_QuarterlyFixedFeesPayableForEachDedicatedManufacturingSuites":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "the quarterly fixed fees payable for each of the dedicated manufacturing suites ranges.",
                            "label":  "Quarterly Fixed Fees Payable for Each Dedicated Manufacturing Suites",
                            "terseLabel":  "Payable For Each Dedicated Manufacturing Suites"
                            }
                        }
                    },
                "localname":  "QuarterlyFixedFeesPayableForEachDedicatedManufacturingSuites",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_RangeOfExercisePricesEightMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the eighth specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices Eight [Member]",
                            "terseLabel":  "$16.51 - $19.75"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesEightMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RangeOfExercisePricesFiveMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the fifth specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices Five [Member]",
                            "terseLabel":  "$10.70 - $11.15"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesFiveMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RangeOfExercisePricesFourMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the fourth specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices Four [Member]",
                            "terseLabel":  "$9.11 - $10.69"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesFourMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RangeOfExercisePricesNineMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the ninth specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices Nine [Member]",
                            "terseLabel":  "$19.76 - $25.78"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesNineMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RangeOfExercisePricesOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the first specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices One [Member]",
                            "terseLabel":  "$5.05 to $5.87"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesOneMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RangeOfExercisePricesSevenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the seventh specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices Seven [Member]",
                            "terseLabel":  "$11.27 - $16.50"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesSevenMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RangeOfExercisePricesSixMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the sixth specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices Six [Member]",
                            "terseLabel":  "$11.16 - $11.26"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesSixMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RangeOfExercisePricesTenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the tenth specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices Ten [Member]",
                            "terseLabel":  "$25.79 - 117.00"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesTenMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RangeOfExercisePricesThreeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the third specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices Three [Member]",
                            "terseLabel":  "$7.56 - $9.10"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesThreeMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RangeOfExercisePricesTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to the second specified range of exercise prices.",
                            "label":  "Range Of Exercise Prices Two [Member]",
                            "terseLabel":  "$5.88 - $7.55"
                            }
                        }
                    },
                "localname":  "RangeOfExercisePricesTwoMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_ResearchCollaborationAndClinicalGrantAgreementsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Research Collaboration And Clinical Grant Agreements [Member]",
                            "terseLabel":  "Research Collaboration And Clinical Grant Agreement"
                            }
                        }
                    },
                "localname":  "ResearchCollaborationAndClinicalGrantAgreementsMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_ResearchCollaborationAndClinicalGrantAgreementsWithMoffittMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Represents the information pertaining to research collaboration and clinical.",
                            "label":  "Research Collaboration And Clinical Grant Agreements With Moffitt [Member]",
                            "terseLabel":  "Research Collaboration And Clinical Grant Agreements With Moffitt"
                            }
                        }
                    },
                "localname":  "ResearchCollaborationAndClinicalGrantAgreementsWithMoffittMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_RestrictedCashPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for restricted cash.",
                            "label":  "Restricted Cash [Policy Text Block]",
                            "terseLabel":  "Restricted Cash"
                            }
                        }
                    },
                "localname":  "RestrictedCashPolicyTextBlock",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "iova_RestrictedCommonStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Restricted Common Stock [Member]",
                            "terseLabel":  "Restricted Common Stock"
                            }
                        }
                    },
                "localname":  "RestrictedCommonStockMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_SanCarlosLeaseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "San Carlos Lease [Member]",
                            "terseLabel":  "San Carlos Lease"
                            }
                        }
                    },
                "localname":  "SanCarlosLeaseMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of cash, cash equivalents and Restricted Cash.",
                            "label":  "Schedule of Cash and Cash Equivalents and Restricted Cash [Table Text Block]",
                            "terseLabel":  "Schedule of cash and cash equivalents and restricted cash"
                            }
                        }
                    },
                "localname":  "ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "iova_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of useful lives of categories of property, plant and equipment.",
                            "label":  "Schedule Of Useful Lives Of Property Plant And Equipment [Table Text Block]"
                            }
                        }
                    },
                "localname":  "ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "iova_SeriesConvertiblePreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Series Convertible Preferred Stock [Member]",
                            "terseLabel":  "Series A Convertible Preferred Stock"
                            }
                        }
                    },
                "localname":  "SeriesConvertiblePreferredStockMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_SeverancePayAndRetentionBonus":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "It represent the value including severance pay and retention bonus.",
                            "label":  "Severance Pay And Retention Bonus",
                            "verboseLabel":  "Severance pay and retention bonus"
                            }
                        }
                    },
                "localname":  "SeverancePayAndRetentionBonus",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_ShareBasedCompensationMaximumAwardPerPerson":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The maximum award per person during a 12-month period according to the share-based compensation plan.",
                            "label":  "Share-based Compensation Maximum Award Per Person",
                            "terseLabel":  "Maximum award per person per year (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationMaximumAwardPerPerson",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "iova_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsadditionaldisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosures [Abstract]",
                            "terseLabel":  "Weighted Average Remaining Contractual Life"
                            }
                        }
                    },
                "localname":  "SharebasedcompensationarrangementbysharebasedpaymentawardoptionsadditionaldisclosuresAbstract",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "iova_SharesSoldUnderIneffectiveRegistration":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of shares that may be sale by the shareholders under ineffective registration statement.",
                            "label":  "Shares sold under ineffective registration"
                            }
                        }
                    },
                "localname":  "SharesSoldUnderIneffectiveRegistration",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "iova_SolomonCapitalLlcLitigationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information pertaining to lawsuit brought by Solomon Capital LLC et al.",
                            "label":  "Solomon Capital Llc Litigation [Member]",
                            "terseLabel":  "Solomon Capital LLC Litigation"
                            }
                        }
                    },
                "localname":  "SolomonCapitalLlcLitigationMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_StevenFischkoffMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Steven Fischkoff [Member]",
                            "terseLabel":  "Steven Fischkoff"
                            }
                        }
                    },
                "localname":  "StevenFischkoffMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_StockCancelledDuringPeriodRestrictedShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of restricted shares cancelled during the period.",
                            "label":  "Stock Cancelled During Period Restricted Shares",
                            "verboseLabel":  "Cancellation of restricted shares (in Shares)"
                            }
                        }
                    },
                "localname":  "StockCancelledDuringPeriodRestrictedShares",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "iova_StockCancelledDuringPeriodSharesOfCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cancellation shares from settlement of dispute.",
                            "label":  "Stock Cancelled During Period Shares Of Common Stock",
                            "terseLabel":  "Cancellation of common shares from settlement of dispute"
                            }
                        }
                    },
                "localname":  "StockCancelledDuringPeriodSharesOfCommonStock",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_StrategicAllianceAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Strategic Alliance Agreement [Member]",
                            "terseLabel":  "Strategic Alliance Agreement"
                            }
                        }
                    },
                "localname":  "StrategicAllianceAgreementMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of supplemental balance sheet information related to leases",
                            "label":  "Supplemental Balance Sheet Information Related To Leases [Table Text Block]",
                            "terseLabel":  "Schedule of balance sheet classification of the Company's right-of-use asset and lease liabilities"
                            }
                        }
                    },
                "localname":  "SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "iova_TampaLeaseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Tampa Lease [Member]",
                            "terseLabel":  "Tampa Lease"
                            }
                        }
                    },
                "localname":  "TampaLeaseMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_TeradataUsIncMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Teradata Us Inc [Member]",
                            "terseLabel":  "Teradata US, Inc"
                            }
                        }
                    },
                "localname":  "TeradataUsIncMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_TwentyEighteenEquityIncentivePlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Twenty Eighteen Equity Incentive Plan Member.",
                            "label":  "Twenty Eighteen Equity Incentive Plan [Member]",
                            "terseLabel":  "The 2018 Plan"
                            }
                        }
                    },
                "localname":  "TwentyEighteenEquityIncentivePlanMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_TwentyElevenEquityIncentivePlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Twenty Eleven Equity Incentive Plan [Member]",
                            "terseLabel":  "Twenty Eleven Equity Incentive Plan"
                            }
                        }
                    },
                "localname":  "TwentyElevenEquityIncentivePlanMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_TwoThousandElevenEquityIncentivePlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Two Thousand Eleven Equity Incentive Plan [Member]",
                            "terseLabel":  "2011 Equity Incentive Plan"
                            }
                        }
                    },
                "localname":  "TwoThousandElevenEquityIncentivePlanMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "iova_UnrealizedGainLossOnShorttermInvestments":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of unrealized (loss)gain on short-term investments.",
                            "label":  "Unrealized Gain Loss on Short-Term Investments",
                            "verboseLabel":  "Net unrealized gain (loss) on short-term investments"
                            }
                        }
                    },
                "localname":  "UnrealizedGainLossOnShorttermInvestments",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "iova_WuxiApptechIncManufacturingAndServicesAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Wuxi Apptech Inc Manufacturing And Services Agreement [Member]",
                            "terseLabel":  "WuXi Apptech, Inc - Manufacturing and Services Agreement"
                            }
                        }
                    },
                "localname":  "WuxiApptechIncManufacturingAndServicesAgreementMember",
                "nsuri":  "http://lbio.com/20191231",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_BoardOfDirectorsChairmanMember":  {
                "auth_ref":  [
                    "r115"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Board Of Directors Chairman [Member]",
                            "terseLabel":  "Board of Directors Chairman"
                            }
                        }
                    },
                "localname":  "BoardOfDirectorsChairmanMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ChiefExecutiveOfficerMember":  {
                "auth_ref":  [
                    "r115"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Chief Executive Officer [Member]",
                            "terseLabel":  "Chief Executive Officer"
                            }
                        }
                    },
                "localname":  "ChiefExecutiveOfficerMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_LitigationCaseAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Litigation Case [Axis]"
                            }
                        }
                    },
                "localname":  "LitigationCaseAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_LitigationCaseTypeDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Litigation Case Type [Domain]",
                            "terseLabel":  "Litigation Case [Domain]"
                            }
                        }
                    },
                "localname":  "LitigationCaseTypeDomain",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Maximum [Member]",
                            "terseLabel":  "Maximum"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Minimum [Member]",
                            "terseLabel":  "Minimum"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Range [Axis]"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Range [Member]",
                            "terseLabel":  "Range [Domain]"
                            }
                        }
                    },
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RestatementAdjustmentMember":  {
                "auth_ref":  [
                    "r91",
                    "r93",
                    "r94",
                    "r95"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Restatement Adjustment [Member]",
                            "terseLabel":  "Restatement Adjustment"
                            }
                        }
                    },
                "localname":  "RestatementAdjustmentMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RestatementAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Restatement [Axis]"
                            }
                        }
                    },
                "localname":  "RestatementAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RestatementDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Restatement [Domain]",
                            "terseLabel":  "Restatement [Domain]"
                            }
                        }
                    },
                "localname":  "RestatementDomain",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_TitleOfIndividualAxis":  {
                "auth_ref":  [
                    "r115",
                    "r309"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Title of Individual [Axis]"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_TitleOfIndividualWithRelationshipToEntityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Title Of Individual With Relationship To Entity [Domain]",
                            "terseLabel":  "Relationship to Entity [Domain]"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualWithRelationshipToEntityDomain",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountingStandardsUpdate201602Member":  {
                "auth_ref":  [
                    "r291"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accounting Standards Update 2016-02 Leases (Topic 842).",
                            "label":  "Accounting Standards Update201602 [Member]",
                            "terseLabel":  "ASU 2016-02"
                            }
                        }
                    },
                "localname":  "AccountingStandardsUpdate201602Member",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountingStandardsUpdate201807Member":  {
                "auth_ref":  [
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accounting Standards Update 2018-07 Compensation-Stock Compensation (Topic 718):  Improvements to Nonemployee Share-Based Payment Accounting.",
                            "label":  "Accounting Standards Update201807 [Member]",
                            "terseLabel":  "Accounting Standards Update 2018-07"
                            }
                        }
                    },
                "localname":  "AccountingStandardsUpdate201807Member",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountsPayableCurrent":  {
                "auth_ref":  [
                    "r35"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accounts Payable, Current",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "AccountsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedEmployeeBenefitsCurrent":  {
                "auth_ref":  [
                    "r6",
                    "r7",
                    "r37"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Employee Benefits, Current",
                            "terseLabel":  "Accrued payroll and employee related expenses"
                            }
                        }
                    },
                "localname":  "AccruedEmployeeBenefitsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r37"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Liabilities, Current",
                            "totalLabel":  "Accrued liabilities",
                            "verboseLabel":  "Accrued expenses"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedRentCurrent":  {
                "auth_ref":  [
                    "r6",
                    "r7",
                    "r37"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Rent, Current",
                            "terseLabel":  "Deferred rent - current"
                            }
                        }
                    },
                "localname":  "AccruedRentCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r33",
                    "r140"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
                            "label":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
                            "negatedLabel":  "Less:  Accumulated depreciation and amortization"
                            }
                        }
                    },
                "localname":  "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax":  {
                "auth_ref":  [
                    "r50",
                    "r51",
                    "r52"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end.  Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.  Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
                            "label":  "Accumulated Other Comprehensive Income (Loss), Net of Tax",
                            "verboseLabel":  "Accumulated other comprehensive loss"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeMember":  {
                "auth_ref":  [
                    "r49",
                    "r52",
                    "r53",
                    "r266"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent.  Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
                            "label":  "Accumulated Other Comprehensive Income [Member]",
                            "terseLabel":  "Accumulated other Comprehensive Income"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "auth_ref":  [
                    "r23"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.  Includes adjustments to additional paid in capital.  Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees.  Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock.  For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock.  For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
                            "label":  "Additional Paid in Capital",
                            "verboseLabel":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapital",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid In Capital [Member]",
                            "terseLabel":  "Additional Paid-in Capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).",
                            "label":  "Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net",
                            "terseLabel":  "Tax payments related to shares withheld for vested restricted stock awards"
                            }
                        }
                    },
                "localname":  "AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis":  {
                "auth_ref":  [
                    "r90"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by new accounting pronouncement.",
                            "label":  "Adjustments for New Accounting Pronouncements [Axis]"
                            }
                        }
                    },
                "localname":  "AdjustmentsForNewAccountingPronouncementsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":  {
                "auth_ref":  [
                    "r180",
                    "r182",
                    "r224",
                    "r225"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
                            "label":  "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition",
                            "verboseLabel":  "Stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Adjustments to reconcile net loss to net cash used in operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AllocatedShareBasedCompensationExpense":  {
                "auth_ref":  [
                    "r182",
                    "r213",
                    "r223"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of expense for award under share-based payment arrangement.  Excludes amount capitalized.",
                            "label":  "Allocated Share-based Compensation Expense",
                            "terseLabel":  "Stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "AllocatedShareBasedCompensationExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfDebtDiscountPremium":  {
                "auth_ref":  [
                    "r64",
                    "r75",
                    "r281"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments.  Excludes amortization of financing costs.  Alternate captions include noncash interest expense.",
                            "label":  "Amortization of Debt Discount (Premium)",
                            "verboseLabel":  "Accretion (amortization) of discounts and premiums on investments"
                            }
                        }
                    },
                "localname":  "AmortizationOfDebtDiscountPremium",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r97"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
                            "terseLabel":  "Antidilutive securities excluded from calculation of net loss per share"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis":  {
                "auth_ref":  [
                    "r97"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of antidilutive security.",
                            "label":  "Antidilutive Securities [Axis]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesNameDomain":  {
                "auth_ref":  [
                    "r97"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
                            "label":  "Antidilutive Securities Name [Domain]",
                            "terseLabel":  "Antidilutive Securities, Name [Domain]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AreaOfLand":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Area of land held.",
                            "label":  "Area of Land"
                            }
                        }
                    },
                "localname":  "AreaOfLand",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "areaItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r114",
                    "r319",
                    "r329"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets",
                            "totalLabel":  "Total Assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r3",
                    "r5",
                    "r46"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Current",
                            "totalLabel":  "Total Current Assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Assets, Current [Abstract]",
                            "verboseLabel":  "Current Assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsFairValueDisclosure":  {
                "auth_ref":  [
                    "r274"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Fair Value Disclosure",
                            "verboseLabel":  "Total"
                            }
                        }
                    },
                "localname":  "AssetsFairValueDisclosure",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis":  {
                "auth_ref":  [
                    "r88"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by securities or other assets sold under repurchase agreements.  Repurchase agreements are agreements under which the transferor (repo party) transfers a security to a transferee (repo counterparty or reverse party) in exchange for cash and concurrently agrees to reacquire that security at a future date for an amount equal to the cash exchanged plus a stipulated interest factor.",
                            "label":  "Securities or Other Assets Sold under Agreements to Repurchase [Axis]"
                            }
                        }
                    },
                "localname":  "AssetsSoldUnderAgreementsToRepurchaseAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain":  {
                "auth_ref":  [
                    "r88"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This is the type of such assets (for example, US Treasury Obligations, US Government agency obligations and loans, and so forth).  This item may be presented as an element in the table that is disclosed when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceed 10 percent of total assets, as of the most recent balance sheet date.",
                            "label":  "Assets Sold Under Agreements To Repurchase Type [Domain]",
                            "terseLabel":  "Assets Sold under Agreements to Repurchase, Type [Domain]"
                            }
                        }
                    },
                "localname":  "AssetsSoldUnderAgreementsToRepurchaseTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AvailableForSaleSecurities":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.",
                            "label":  "Available-for-sale Securities",
                            "verboseLabel":  "Fair Value"
                            }
                        }
                    },
                "localname":  "AvailableForSaleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax":  {
                "auth_ref":  [
                    "r118"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.",
                            "label":  "Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax",
                            "verboseLabel":  "Gross Unrealized Gains"
                            }
                        }
                    },
                "localname":  "AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.",
                            "label":  "Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax",
                            "negatedLabel":  "Gross Unrealized Losses"
                            }
                        }
                    },
                "localname":  "AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AvailableForSaleSecuritiesAmortizedCost":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.",
                            "label":  "Available-for-sale Securities, Amortized Cost Basis",
                            "verboseLabel":  "Cost"
                            }
                        }
                    },
                "localname":  "AvailableForSaleSecuritiesAmortizedCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AwardTypeAxis":  {
                "auth_ref":  [
                    "r183",
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of award under share-based payment arrangement.",
                            "label":  "Award Type [Axis]"
                            }
                        }
                    },
                "localname":  "AwardTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationByInstrumentDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock":  {
                "auth_ref":  [
                    "r0",
                    "r89",
                    "r110"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
                            "label":  "Business Description and Basis of Presentation [Text Block]",
                            "verboseLabel":  "GENERAL ORGANIZATION AND BUSINESS"
                            }
                        }
                    },
                "localname":  "BusinessDescriptionAndBasisOfPresentationTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureGeneralOrganizationAndBusiness"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r1",
                    "r30",
                    "r77"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                        "weight":  1.0
                        },
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "definitionGuidance":  "Cash equivalents total",
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash and Cash Equivalents, at Carrying Value",
                            "terseLabel":  "Cash",
                            "verboseLabel":  "Cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureGeneralOrganizationAndBusinessDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of cash and cash equivalent balance.",
                            "label":  "Cash and Cash Equivalents [Axis]"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashAndCashEquivalentsPolicyTextBlock":  {
                "auth_ref":  [
                    "r12",
                    "r78",
                    "r83"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents.  Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
                            "label":  "Cash and Cash Equivalents, Policy [Policy Text Block]",
                            "verboseLabel":  "Cash, Cash Equivalents, and Short-term Investments"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsAndShortTermInvestmentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock":  {
                "auth_ref":  [
                    "r12",
                    "r119"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure of the components of cash, cash equivalents, and short-term investments.  Short-term investments may include current marketable securities.",
                            "label":  "Cash, Cash Equivalents, and Short-term Investments [Text Block]",
                            "terseLabel":  "CASH AND CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsAndShortTermInvestmentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestments"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r72",
                    "r77",
                    "r82"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage.  Excludes amount for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
                            "periodEndLabel":  "Cash, Cash Equivalents, and Restricted Cash End of Period",
                            "periodStartLabel":  "Cash, Cash Equivalents, and Restricted Cash Beginning of Period",
                            "totalLabel":  "Total cash, cash equivalents and restricted cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r72",
                    "r280"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
                            "totalLabel":  "Net (decrease) increase in cash, cash equivalents and restricted cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
                            "verboseLabel":  "Supplemental disclosure of non-cash investing and financing activities:"
                            }
                        }
                    },
                "localname":  "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ClassOfStockDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
                            "label":  "Class Of Stock [Domain]",
                            "terseLabel":  "Class of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "ClassOfStockDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ClassOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Class of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "ClassOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommercialPaperMember":  {
                "auth_ref":  [
                    "r153"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
                            "label":  "Commercial Paper [Member]",
                            "terseLabel":  "Commercial Paper"
                            }
                        }
                    },
                "localname":  "CommercialPaperMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance":  {
                "auth_ref":  [
                    "r42"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Aggregate number of common shares reserved for future issuance.",
                            "label":  "Common Stock, Capital Shares Reserved for Future Issuance",
                            "terseLabel":  "Common stock, capital shares reserved for future issuance"
                            }
                        }
                    },
                "localname":  "CommonStockCapitalSharesReservedForFutureIssuance",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]",
                            "terseLabel":  "Common Stock"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r22"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Common stock, par or stated value per share"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r22"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common Stock, Shares Authorized",
                            "verboseLabel":  "Common stock, shares authorized"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r22"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common Stock, Shares, Issued"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r22",
                    "r159"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common Stock, Shares, Outstanding"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r22"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common Stock, Value, Issued",
                            "terseLabel":  "Common stock, $0.000041666 par value; 300,000,000 and 150,000,000 shares authorized, 126,411,808 and 123,415,576 shares issued and outstanding as of December 31, 2019 and December 31, 2018, respectively"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock":  {
                "auth_ref":  [
                    "r172",
                    "r173",
                    "r179",
                    "r226"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
                            "label":  "Compensation and Employee Benefit Plans [Text Block]",
                            "verboseLabel":  "EMPLOYEE BENEFIT PLAN"
                            }
                        }
                    },
                "localname":  "CompensationAndEmployeeBenefitPlansTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureEmployeeBenefitPlan"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CompensationAndRetirementDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "EMPLOYEE BENEFIT PLAN"
                            }
                        }
                    },
                "localname":  "CompensationAndRetirementDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTax":  {
                "auth_ref":  [
                    "r55",
                    "r57",
                    "r58"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity.  Excludes changes in equity resulting from investments by owners and distributions to owners.",
                            "label":  "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
                            "totalLabel":  "Comprehensive Loss"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComputerEquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
                            "label":  "Computer Equipment [Member]",
                            "terseLabel":  "Computer equipment"
                            }
                        }
                    },
                "localname":  "ComputerEquipmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConcentrationRiskCreditRisk":  {
                "auth_ref":  [
                    "r104",
                    "r327"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for credit risk.",
                            "label":  "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
                            "verboseLabel":  "Concentrations"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskCreditRisk",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConsolidationPolicyTextBlock":  {
                "auth_ref":  [
                    "r83",
                    "r265",
                    "r267",
                    "r268"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
                            "label":  "Consolidation, Policy [Policy Text Block]",
                            "verboseLabel":  "Principles of Consolidation"
                            }
                        }
                    },
                "localname":  "ConsolidationPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConstructionInProgressMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Structure or a modification to a structure under construction.  Includes recently completed structures or modifications to structures that have not been placed into service.",
                            "label":  "Construction In Progress [Member]",
                            "terseLabel":  "Construction in progress"
                            }
                        }
                    },
                "localname":  "ConstructionInProgressMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConversionOfStockAmountConverted1":  {
                "auth_ref":  [
                    "r79",
                    "r80",
                    "r81"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The value of the stock converted in a noncash (or part noncash) transaction.  Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Conversion of Stock, Amount Converted",
                            "terseLabel":  "Conversion of convertible preferred stock to common stock"
                            }
                        }
                    },
                "localname":  "ConversionOfStockAmountConverted1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConversionOfStockByUniqueDescriptionAxis":  {
                "auth_ref":  [
                    "r79",
                    "r80",
                    "r81"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by description of stock conversions.",
                            "label":  "Stock Conversion Description [Axis]"
                            }
                        }
                    },
                "localname":  "ConversionOfStockByUniqueDescriptionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConversionOfStockNameDomain":  {
                "auth_ref":  [
                    "r79",
                    "r80",
                    "r81"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The unique name of a noncash or part noncash stock conversion.",
                            "label":  "Conversion Of Stock Name [Domain]",
                            "terseLabel":  "Conversion of Stock, Name [Domain]"
                            }
                        }
                    },
                "localname":  "ConversionOfStockNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConversionOfStockSharesConverted1":  {
                "auth_ref":  [
                    "r79",
                    "r80",
                    "r81"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of shares converted in a noncash (or part noncash) transaction.  Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Conversion of Stock, Shares Converted",
                            "terseLabel":  "Conversion of Stock, shares converted"
                            }
                        }
                    },
                "localname":  "ConversionOfStockSharesConverted1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ConversionOfStockSharesIssued1":  {
                "auth_ref":  [
                    "r79",
                    "r80",
                    "r81"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction.  Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Conversion of Stock, Shares Issued",
                            "terseLabel":  "Conversion of stock, shares issued"
                            }
                        }
                    },
                "localname":  "ConversionOfStockSharesIssued1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
                            "label":  "Cumulative Effect of New Accounting Principle in Period of Adoption",
                            "verboseLabel":  "Adoption of ASU 2018-07"
                            }
                        }
                    },
                "localname":  "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CurrentFederalTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r84",
                    "r256",
                    "r261"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Current Federal Tax Expense (Benefit)",
                            "verboseLabel":  "Current"
                            }
                        }
                    },
                "localname":  "CurrentFederalTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CurrentStateAndLocalTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r84",
                    "r256",
                    "r261"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Current State and Local Tax Expense (Benefit)",
                            "verboseLabel":  "Current"
                            }
                        }
                    },
                "localname":  "CurrentStateAndLocalTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments":  {
                "auth_ref":  [
                    "r39",
                    "r160",
                    "r163",
                    "r165"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.",
                            "label":  "Debt Instrument, Convertible, Number of Equity Instruments",
                            "terseLabel":  "Debt instrument, convertible, number of equity instruments"
                            }
                        }
                    },
                "localname":  "DebtInstrumentConvertibleNumberOfEquityInstruments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_DebtInstrumentFaceAmount":  {
                "auth_ref":  [
                    "r282",
                    "r283"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Face (par) amount of debt instrument at time of issuance.",
                            "label":  "Debt Instrument, Face Amount",
                            "terseLabel":  "Face amount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentFaceAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredFederalIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r84",
                    "r257",
                    "r261"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred Federal Income Tax Expense (Benefit)",
                            "verboseLabel":  "Deferred"
                            }
                        }
                    },
                "localname":  "DeferredFederalIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r84",
                    "r257",
                    "r261"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred State and Local Income Tax Expense (Benefit)",
                            "verboseLabel":  "Deferred"
                            }
                        }
                    },
                "localname":  "DeferredStateAndLocalIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsGross":  {
                "auth_ref":  [
                    "r248"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
                            "label":  "Deferred Tax Assets, Gross",
                            "totalLabel":  "Deferred tax assets before valuation allowance"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsGross",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsLiabilitiesNet":  {
                "auth_ref":  [
                    "r251"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
                            "label":  "Deferred Tax Assets, Net",
                            "totalLabel":  "Net deferred tax assets (liabilities)"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsLiabilitiesNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsNet":  {
                "auth_ref":  [
                    "r249"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsLiabilitiesNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
                            "label":  "Deferred Tax Assets, Net of Valuation Allowance",
                            "totalLabel":  "Net deferred income tax assets"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsNetAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Net [Abstract]",
                            "terseLabel":  "Deferred income tax asset:"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsNetAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards":  {
                "auth_ref":  [
                    "r231",
                    "r254",
                    "r255"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
                            "label":  "Deferred Tax Assets, Operating Loss Carryforwards",
                            "verboseLabel":  "Net operating loss carry forward"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOperatingLossCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards":  {
                "auth_ref":  [
                    "r253",
                    "r254",
                    "r255"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
                            "label":  "Deferred Tax Assets, Tax Credit Carryforwards",
                            "terseLabel":  "Tax credit carryforwards"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxCreditCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost":  {
                "auth_ref":  [
                    "r231",
                    "r254",
                    "r255"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
                            "label":  "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
                            "terseLabel":  "Stock-based compensation"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals":  {
                "auth_ref":  [
                    "r232",
                    "r254",
                    "r255"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
                            "label":  "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
                            "terseLabel":  "Reserves and accruals"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r250"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
                            "label":  "Deferred Tax Assets, Valuation Allowance",
                            "negatedLabel":  "Less: valuation allowance"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxLiabilitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Deferred Tax Liabilities, Gross [Abstract]",
                            "terseLabel":  "Deferred tax liabilities:"
                            }
                        }
                    },
                "localname":  "DeferredTaxLiabilitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DefinedContributionPlanCostRecognized":  {
                "auth_ref":  [
                    "r178"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cost for defined contribution plan.",
                            "label":  "Defined Contribution Plan, Cost"
                            }
                        }
                    },
                "localname":  "DefinedContributionPlanCostRecognized",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureEmployeeBenefitPlanDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DemandDepositsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice.  Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
                            "label":  "Demand Deposits [Member]",
                            "terseLabel":  "Demand Deposits"
                            }
                        }
                    },
                "localname":  "DemandDepositsMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Depreciation":  {
                "auth_ref":  [
                    "r75",
                    "r138"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives.  Includes production and non-production related depreciation.",
                            "label":  "Depreciation"
                            }
                        }
                    },
                "localname":  "Depreciation",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsOtherInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DepreciationDepletionAndAmortization":  {
                "auth_ref":  [
                    "r75",
                    "r112"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
                            "label":  "Depreciation, Depletion and Amortization, Nonproduction",
                            "verboseLabel":  "Depreciation and amortization"
                            }
                        }
                    },
                "localname":  "DepreciationDepletionAndAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock":  {
                "auth_ref":  [
                    "r226"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for share-based payment arrangement.",
                            "label":  "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]",
                            "terseLabel":  "STOCK BASED COMPENSATION"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensation"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "STOCK BASED COMPENSATION"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DomesticCountryMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
                            "label":  "Domestic Country [Member]",
                            "terseLabel":  "Domestic Tax Authority [Member]"
                            }
                        }
                    },
                "localname":  "DomesticCountryMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EarningsPerShareBasicAndDiluted":  {
                "auth_ref":  [
                    "r96"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Basic and Diluted",
                            "terseLabel":  "Net loss per share, basic and diluted",
                            "verboseLabel":  "Net Loss Per Common Share, Basic and Diluted"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasicAndDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureQuarterlyUnauditedResultsDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerSharePolicyTextBlock":  {
                "auth_ref":  [
                    "r83",
                    "r97",
                    "r98",
                    "r99"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security.  Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
                            "label":  "Earnings Per Share, Policy [Policy Text Block]",
                            "verboseLabel":  "Loss per Share"
                            }
                        }
                    },
                "localname":  "EarningsPerSharePolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateContinuingOperations":  {
                "auth_ref":  [
                    "r87",
                    "r237",
                    "r238"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Effective Income Tax Rate Reconciliation, Percent",
                            "totalLabel":  "Effective tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateContinuingOperations",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate":  {
                "auth_ref":  [
                    "r237",
                    "r238",
                    "r260"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
                            "label":  "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
                            "negatedLabel":  "Federal statutory tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r237",
                    "r238",
                    "r260"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
                            "verboseLabel":  "Valuation allowance"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate":  {
                "auth_ref":  [
                    "r237",
                    "r238",
                    "r260"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
                            "terseLabel":  "Tax rate change"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments":  {
                "auth_ref":  [
                    "r237",
                    "r238",
                    "r260"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
                            "label":  "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
                            "verboseLabel":  "Permanent and other differences"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits":  {
                "auth_ref":  [
                    "r237",
                    "r238",
                    "r260"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits.  Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
                            "label":  "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
                            "verboseLabel":  "Orphan Drug & Research credits"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationTaxCredits",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal":  {
                "auth_ref":  [
                    "r237",
                    "r238",
                    "r260"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax settlement.",
                            "label":  "Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent",
                            "verboseLabel":  "State tax, net of federal benefit"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1":  {
                "auth_ref":  [
                    "r214"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition",
                            "terseLabel":  "Unrecognized compensation cost recognition period"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions":  {
                "auth_ref":  [
                    "r214"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cost to be recognized for nonvested award under share-based payment arrangement.  Excludes share and unit options.",
                            "label":  "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options",
                            "terseLabel":  "Unrecognized compensation cost"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":  {
                "auth_ref":  [
                    "r214"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cost to be recognized for option under share-based payment arrangement.",
                            "label":  "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options",
                            "terseLabel":  "Unrecognized compensation cost"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeStockOptionMember":  {
                "auth_ref":  [
                    "r211"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
                            "label":  "Employee Stock Option [Member]",
                            "terseLabel":  "Stock option"
                            }
                        }
                    },
                "localname":  "EmployeeStockOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationByInstrumentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tangible personal property used to produce goods and services.",
                            "label":  "Equipment [Member]",
                            "terseLabel":  "Lab equipment"
                            }
                        }
                    },
                "localname":  "EquipmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r159"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
                            "label":  "Equity Component [Domain]",
                            "terseLabel":  "Equity Component [Domain]"
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock":  {
                "auth_ref":  [
                    "r274",
                    "r275"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis.  The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
                            "label":  "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
                            "verboseLabel":  "Schedule of assets measured at fair value"
                            }
                        }
                    },
                "localname":  "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueByFairValueHierarchyLevelAxis":  {
                "auth_ref":  [
                    "r174",
                    "r175",
                    "r177",
                    "r275",
                    "r312"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
                            "label":  "Fair Value Hierarchy and NAV [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByFairValueHierarchyLevelAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueByMeasurementFrequencyAxis":  {
                "auth_ref":  [
                    "r274",
                    "r275",
                    "r276",
                    "r277",
                    "r279"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by measurement frequency.",
                            "label":  "Measurement Frequency [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByMeasurementFrequencyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueInputsLevel1Member":  {
                "auth_ref":  [
                    "r174",
                    "r175",
                    "r177",
                    "r275",
                    "r313"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
                            "label":  "Fair Value Inputs Level1 [Member]",
                            "terseLabel":  "Level 1"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel1Member",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueInputsLevel2Member":  {
                "auth_ref":  [
                    "r174",
                    "r175",
                    "r177",
                    "r275",
                    "r314"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
                            "label":  "Fair Value Inputs Level2 [Member]",
                            "terseLabel":  "Level 2"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel2Member",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueInputsLevel3Member":  {
                "auth_ref":  [
                    "r174",
                    "r175",
                    "r177",
                    "r275",
                    "r315"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
                            "label":  "Fair Value Inputs Level3 [Member]",
                            "terseLabel":  "Level 3"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel3Member",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementFrequencyDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Measurement frequency.",
                            "label":  "Fair Value Measurement Frequency [Domain]",
                            "terseLabel":  "Fair Value, Measurement Frequency [Domain]"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementFrequencyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity.  Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
                            "label":  "Fair Value Measurement, Policy [Policy Text Block]",
                            "verboseLabel":  "Fair Value Measurements"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueMeasurementsFairValueHierarchyDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
                            "label":  "Fair Value Measurements Fair Value Hierarchy [Domain]",
                            "terseLabel":  "Fair Value Hierarchy and NAV [Domain]"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsFairValueHierarchyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementsRecurringMember":  {
                "auth_ref":  [
                    "r278",
                    "r279"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Frequent fair value measurement.  Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
                            "label":  "Fair Value Measurements Recurring [Member]",
                            "terseLabel":  "Fair Value, Measurements, Recurring"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsRecurringMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]",
                            "verboseLabel":  "Federal:"
                            }
                        }
                    },
                "localname":  "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FinancialInstrumentAxis":  {
                "auth_ref":  [
                    "r120",
                    "r121",
                    "r122",
                    "r123",
                    "r124",
                    "r125",
                    "r126",
                    "r127",
                    "r128"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of financial instrument.",
                            "label":  "Financial Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "FinancialInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r130",
                    "r131",
                    "r133",
                    "r134",
                    "r317"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by major type or class of finite-lived intangible assets.",
                            "label":  "Finite-Lived Intangible Assets by Major Class [Axis]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r130",
                    "r132"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
                            "label":  "Finite Lived Intangible Assets Major Class Name [Domain]",
                            "terseLabel":  "Finite-Lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_GainLossOnDispositionOfAssets":  {
                "auth_ref":  [
                    "r75",
                    "r137",
                    "r143"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
                            "label":  "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
                            "negatedLabel":  "Loss on disposal of assets"
                            }
                        }
                    },
                "localname":  "GainLossOnDispositionOfAssets",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GainLossRelatedToLitigationSettlement":  {
                "auth_ref":  [
                    "r145"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of gain (loss) recognized in settlement of litigation and insurance claims.  Excludes claims within an insurance entity's normal claims settlement process.",
                            "label":  "Gain (Loss) Related to Litigation Settlement",
                            "negatedLabel":  "Gain on settlement of dispute"
                            }
                        }
                    },
                "localname":  "GainLossRelatedToLitigationSettlement",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r62"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
                            "label":  "General and Administrative Expense",
                            "verboseLabel":  "General and administrative expenses"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpenseMember":  {
                "auth_ref":  [
                    "r61"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing general and administrative expense.",
                            "label":  "General And Administrative Expense [Member]",
                            "terseLabel":  "General and administrative"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationExpenseDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse":  {
                "auth_ref":  [
                    "r75",
                    "r136",
                    "r142",
                    "r336"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
                            "label":  "Impairment of Long-Lived Assets Held-for-use"
                            }
                        }
                    },
                "localname":  "ImpairmentOfLongLivedAssetsHeldForUse",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Condensed Consolidated Statements of Operations"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationAxis":  {
                "auth_ref":  [
                    "r144"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by location in the income statement.",
                            "label":  "Income Statement Location [Axis]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationExpenseDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Location in the income statement.",
                            "label":  "Income Statement Location [Domain]",
                            "terseLabel":  "Income Statement Location [Domain]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationExpenseDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxAuthorityAxis":  {
                "auth_ref":  [
                    "r240"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by tax jurisdiction.",
                            "label":  "Income Tax Authority [Axis]"
                            }
                        }
                    },
                "localname":  "IncomeTaxAuthorityAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxAuthorityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
                            "label":  "Income Tax Authority [Domain]",
                            "terseLabel":  "Income Tax Authority [Domain]"
                            }
                        }
                    },
                "localname":  "IncomeTaxAuthorityDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxContingencyLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Income Tax Contingency [Line Items]"
                            }
                        }
                    },
                "localname":  "IncomeTaxContingencyLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxContingencyTable":  {
                "auth_ref":  [
                    "r241",
                    "r245",
                    "r247",
                    "r259"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies.  Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
                            "label":  "Income Tax Contingency [Table]"
                            }
                        }
                    },
                "localname":  "IncomeTaxContingencyTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "INCOME TAXES"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureTextBlock":  {
                "auth_ref":  [
                    "r264"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for income taxes.  Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
                            "label":  "Income Tax Disclosure [Text Block]",
                            "verboseLabel":  "INCOME TAXES"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxes"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense":  {
                "auth_ref":  [
                    "r239"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
                            "label":  "Income Tax Examination, Penalties and Interest Expense",
                            "terseLabel":  "Interest or penalties on unpaid tax"
                            }
                        }
                    },
                "localname":  "IncomeTaxExaminationPenaltiesAndInterestExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r84",
                    "r113",
                    "r262"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Income Tax Expense (Benefit)",
                            "totalLabel":  "Total income tax expense (benefit)"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "auth_ref":  [
                    "r59",
                    "r83",
                    "r235",
                    "r236",
                    "r246",
                    "r247",
                    "r252",
                    "r263",
                    "r335"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
                            "label":  "Income Tax, Policy [Policy Text Block]",
                            "verboseLabel":  "Income taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r234",
                    "r237",
                    "r238"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
                            "terseLabel":  "Change in Valuation Allowance"
                            }
                        }
                    },
                "localname":  "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayable":  {
                "auth_ref":  [
                    "r74"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
                            "label":  "Increase (Decrease) in Accounts Payable",
                            "verboseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccruedLiabilities":  {
                "auth_ref":  [
                    "r74"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
                            "label":  "Increase (Decrease) in Accrued Liabilities",
                            "verboseLabel":  "Accrued expenses and other liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Operating Capital [Abstract]",
                            "terseLabel":  "Changes in assets and liabilities:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":  {
                "auth_ref":  [
                    "r74"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
                            "label":  "Increase (Decrease) in Prepaid Expense and Other Assets",
                            "negatedLabel":  "Prepaid expenses, other assets, and long-term assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InvestmentIncomeInterest":  {
                "auth_ref":  [
                    "r63",
                    "r111"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
                            "label":  "Investment Income, Interest",
                            "verboseLabel":  "Interest income, net"
                            }
                        }
                    },
                "localname":  "InvestmentIncomeInterest",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LandMember":  {
                "auth_ref":  [
                    "r171"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Part of earth's surface not covered by water.",
                            "label":  "Land [Member]",
                            "terseLabel":  "Land"
                            }
                        }
                    },
                "localname":  "LandMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LeaseAndRentalExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
                            "label":  "Operating Leases, Rent Expense"
                            }
                        }
                    },
                "localname":  "LeaseAndRentalExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseArrangementTypeAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by group of related lease arrangements.  For example, but not limited to, leases grouped by facility or contractual terms.",
                            "label":  "Lease Arrangement, Type [Axis]"
                            }
                        }
                    },
                "localname":  "LeaseArrangementTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LeaseArrangementTypeDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Group of related lease arrangements.  For example, but not limited to, leases grouped by facility or contractual terms.",
                            "label":  "Lease Arrangement Type [Domain]",
                            "terseLabel":  "Lease Arrangement, Type [Domain]"
                            }
                        }
                    },
                "localname":  "LeaseArrangementTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LeaseCost":  {
                "auth_ref":  [
                    "r305",
                    "r306"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lease cost recognized by lessee for lease contract.",
                            "label":  "Lease, Cost",
                            "totalLabel":  "Total lease cost"
                            }
                        }
                    },
                "localname":  "LeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseCostTableTextBlock":  {
                "auth_ref":  [
                    "r305"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of lessee's lease cost.  Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
                            "label":  "Lease, Cost [Table Text Block]",
                            "terseLabel":  "Schedule of components of lease expenses"
                            }
                        }
                    },
                "localname":  "LeaseCostTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LeasePracticalExpedientsPackage":  {
                "auth_ref":  [
                    "r289",
                    "r290"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicates (true false) whether practical expedients are elected for not reassessing whether any expired or existing contract is or contains lease, lease classification for expired or existing lease, and initial direct cost for any existing lease.",
                            "label":  "Lease, Practical Expedients, Package [true false]"
                            }
                        }
                    },
                "localname":  "LeasePracticalExpedientsPackage",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "us-gaap_LeaseholdImprovementsMember":  {
                "auth_ref":  [
                    "r139"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Additions or improvements to assets held under a lease arrangement.",
                            "label":  "Leasehold Improvements [Member]",
                            "terseLabel":  "Leasehold improvements"
                            }
                        }
                    },
                "localname":  "LeaseholdImprovementsMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LeasesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "LEASES"
                            }
                        }
                    },
                "localname":  "LeasesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LesseeFinanceLeaseLeaseNotYetCommencedTermOfContract1":  {
                "auth_ref":  [
                    "r298"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Term of lessee's finance lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Lessee, Finance Lease, Lease Not yet Commenced, Term of Contract",
                            "terseLabel":  "Finance lease term for not yet commenced (in years)"
                            }
                        }
                    },
                "localname":  "LesseeFinanceLeaseLeaseNotYetCommencedTermOfContract1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_LesseeLeasesPolicyTextBlock":  {
                "auth_ref":  [
                    "r296"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
                            "label":  "Lessee, Leases [Policy Text Block]",
                            "terseLabel":  "Leases"
                            }
                        }
                    },
                "localname":  "LesseeLeasesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeOperatingLeaseOptionToExtend":  {
                "auth_ref":  [
                    "r297"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Description of terms and conditions of option to extend lessee's operating lease.  Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
                            "label":  "Lessee, Operating Lease, Option to Extend",
                            "verboseLabel":  "Option to extend"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseOptionToExtend",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LesseeOperatingLeaseRenewalTerm":  {
                "auth_ref":  [
                    "r297"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Lessee, Operating Lease, Renewal Term",
                            "terseLabel":  "Renewal term (in months)"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseRenewalTerm",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_LesseeOperatingLeaseTermOfContract":  {
                "auth_ref":  [
                    "r297"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Lessee, Operating Lease, Term of Contract",
                            "terseLabel":  "Term of contract (in years)"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseTermOfContract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_LesseeOperatingLeasesTextBlock":  {
                "auth_ref":  [
                    "r307"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for operating leases of lessee.  Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
                            "label":  "Lessee, Operating Leases [Text Block]",
                            "terseLabel":  "LEASES"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeasesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeases"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LettersOfCreditOutstandingAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
                            "label":  "Letters of Credit Outstanding, Amount",
                            "terseLabel":  "Letter of credit"
                            }
                        }
                    },
                "localname":  "LettersOfCreditOutstandingAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Liabilities":  {
                "auth_ref":  [
                    "r36"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized.  Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
                            "label":  "Liabilities",
                            "totalLabel":  "Total Liabilities"
                            }
                        }
                    },
                "localname":  "Liabilities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r27",
                    "r320",
                    "r332"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "Total Liabilities and Stockholders' Equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r38"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total Current Liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Liabilities, Current [Abstract]",
                            "verboseLabel":  "Current Liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesNoncurrent":  {
                "auth_ref":  [
                    "r9",
                    "r10",
                    "r11",
                    "r16",
                    "r17"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
                            "label":  "Liabilities, Noncurrent",
                            "totalLabel":  "Total Non-Current Liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesNoncurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Liabilities, Noncurrent [Abstract]",
                            "verboseLabel":  "Non-Current Liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesNoncurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by category of items purchased under a long-term purchase commitment.",
                            "label":  "Category of Item Purchased [Axis]"
                            }
                        }
                    },
                "localname":  "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.",
                            "label":  "Long Term Purchase Commitment Category Of Item Purchased [Domain]",
                            "terseLabel":  "Long-term Purchase Commitment, Category of Item Purchased [Domain]"
                            }
                        }
                    },
                "localname":  "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LossContingencyAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "LEGAL PROCEEDINGS"
                            }
                        }
                    },
                "localname":  "LossContingencyAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LossContingencyClaimsDismissedNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of claims dismissed.",
                            "label":  "Loss Contingency, Claims Dismissed, Number"
                            }
                        }
                    },
                "localname":  "LossContingencyClaimsDismissedNumber",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_LossContingencyDamagesSoughtValue":  {
                "auth_ref":  [
                    "r145",
                    "r146",
                    "r148"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
                            "label":  "Loss Contingency, Damages Sought, Value",
                            "verboseLabel":  "Damages claimed"
                            }
                        }
                    },
                "localname":  "LossContingencyDamagesSoughtValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LossContingencyDisclosures":  {
                "auth_ref":  [
                    "r150",
                    "r151"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for loss and gain contingencies.  Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
                            "label":  "Contingencies Disclosure [Text Block]",
                            "verboseLabel":  "LEGAL PROCEEDINGS"
                            }
                        }
                    },
                "localname":  "LossContingencyDisclosures",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedings"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LossContingencyEstimateOfPossibleLoss":  {
                "auth_ref":  [
                    "r147",
                    "r149",
                    "r152"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
                            "label":  "Loss Contingency, Estimate of Possible Loss",
                            "terseLabel":  "Estimate of possible loss"
                            }
                        }
                    },
                "localname":  "LossContingencyEstimateOfPossibleLoss",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LossContingencyNumberOfDefendants":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of defendants named in a legal action.",
                            "label":  "Loss Contingency, Number of Defendants"
                            }
                        }
                    },
                "localname":  "LossContingencyNumberOfDefendants",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_LossContingencyPendingClaimsNumber":  {
                "auth_ref":  [
                    "r146"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of pending claims pertaining to a loss contingency.",
                            "label":  "Loss Contingency, Pending Claims, Number"
                            }
                        }
                    },
                "localname":  "LossContingencyPendingClaimsNumber",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_MoneyMarketFundsMember":  {
                "auth_ref":  [
                    "r174"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
                            "label":  "Money Market Funds [Member]",
                            "terseLabel":  "Money Market Funds"
                            }
                        }
                    },
                "localname":  "MoneyMarketFundsMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r72"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash provided by financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Financing Activities [Abstract]",
                            "verboseLabel":  "Cash Flows from Financing Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "auth_ref":  [
                    "r72"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "totalLabel":  "Net cash provided by (used in) investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Investing Activities [Abstract]",
                            "verboseLabel":  "Cash Flows from Investing Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r72",
                    "r73",
                    "r76"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net cash used in operating activities",
                            "verboseLabel":  "Net cash used in operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureGeneralOrganizationAndBusinessDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Operating Activities [Abstract]",
                            "verboseLabel":  "Cash Flows from Operating Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r54",
                    "r56",
                    "r60",
                    "r76",
                    "r98",
                    "r326",
                    "r334"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0
                        },
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "definitionGuidance":  "Net loss",
                            "disclosureGuidance":  "Net loss",
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net Income (Loss) Attributable to Parent",
                            "totalLabel":  "Net Loss",
                            "verboseLabel":  "Net Loss"
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureGeneralOrganizationAndBusinessDetails",
                    "http://lbio.com/role/DisclosureQuarterlyUnauditedResultsDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable":  {
                "auth_ref":  [
                    "r90",
                    "r92"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
                            "label":  "New Accounting Pronouncements or Change in Accounting Principle [Table]"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "New Accounting Pronouncements, Policy [Policy Text Block]",
                            "terseLabel":  "Recent Accounting Standards"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NonoperatingIncomeExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Nonoperating Income (Expense) [Abstract]",
                            "verboseLabel":  "Other income"
                            }
                        }
                    },
                "localname":  "NonoperatingIncomeExpenseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NumberOfOperatingSegments":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of operating segments.  An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available.  An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
                            "label":  "Number of Operating Segments",
                            "verboseLabel":  "Number of operating segment"
                            }
                        }
                    },
                "localname":  "NumberOfOperatingSegments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_OfficeEquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tangible personal property used in an office setting.  Examples include, but are not limited to, computers, copiers and fax machine.",
                            "label":  "Office Equipment [Member]",
                            "terseLabel":  "Office furniture and equipment"
                            }
                        }
                    },
                "localname":  "OfficeEquipmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OperatingExpenses":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services.  Includes selling, general and administrative expense.",
                            "label":  "Operating Expenses",
                            "totalLabel":  "Total costs and expenses"
                            }
                        }
                    },
                "localname":  "OperatingExpenses",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Operating Expenses [Abstract]",
                            "verboseLabel":  "Costs and expenses"
                            }
                        }
                    },
                "localname":  "OperatingExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "totalLabel":  "Loss from operations"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseCost":  {
                "auth_ref":  [
                    "r299",
                    "r306"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LeaseCost",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term.  Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
                            "label":  "Operating Lease, Cost",
                            "verboseLabel":  "Operating lease cost"
                            }
                        }
                    },
                "localname":  "OperatingLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseExpense":  {
                "auth_ref":  [
                    "r294"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of operating lease expense.  Excludes sublease income.",
                            "label":  "Operating Lease, Expense",
                            "terseLabel":  "Operating expenses"
                            }
                        }
                    },
                "localname":  "OperatingLeaseExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiability":  {
                "auth_ref":  [
                    "r293"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetailsCalc2":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease.",
                            "label":  "Operating Lease, Liability",
                            "totalLabel":  "Total operating lease liabilities",
                            "verboseLabel":  "Operating lease liabilities"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails",
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r293"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        },
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
                            "label":  "Operating Lease, Liability, Current",
                            "netLabel":  "Operating lease liabilities - current",
                            "terseLabel":  "Operating lease liabilities",
                            "verboseLabel":  "Current portion included in current liabilities"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r293"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        },
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
                            "label":  "Operating Lease, Liability, Noncurrent",
                            "netLabel":  "Operating lease liabilities - noncurrent",
                            "terseLabel":  "Operating lease liabilities",
                            "verboseLabel":  "Long-term portion included in non-current liabilities"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasePayments":  {
                "auth_ref":  [
                    "r295",
                    "r302"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
                            "label":  "Operating Lease, Payments",
                            "terseLabel":  "Monthly lease payments"
                            }
                        }
                    },
                "localname":  "OperatingLeasePayments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseRightOfUseAsset":  {
                "auth_ref":  [
                    "r292"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's right to use underlying asset under operating lease.",
                            "label":  "Operating Lease, Right-of-Use Asset",
                            "terseLabel":  "Operating lease right-of-use assets"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightOfUseAsset",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent":  {
                "auth_ref":  [
                    "r304",
                    "r306"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average discount rate for operating lease calculated at point in time.",
                            "label":  "Operating Lease, Weighted Average Discount Rate, Percent",
                            "terseLabel":  "Weighted average discount rate (as a percent)"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageDiscountRatePercent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1":  {
                "auth_ref":  [
                    "r303",
                    "r306"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Operating Lease, Weighted Average Remaining Lease Term",
                            "terseLabel":  "Weighted average remaining lease term (in years)"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDue":  {
                "auth_ref":  [
                    "r285",
                    "r287"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetailsCalc2":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
                            "label":  "Operating Leases, Future Minimum Payments Due",
                            "terseLabel":  "Monthly lease payments",
                            "totalLabel":  "Total lease payments"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears":  {
                "auth_ref":  [
                    "r285",
                    "r287"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Due in Five Years",
                            "verboseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears":  {
                "auth_ref":  [
                    "r285",
                    "r287"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Due in Four Years",
                            "verboseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears":  {
                "auth_ref":  [
                    "r285",
                    "r287"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Due in Three Years",
                            "verboseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears":  {
                "auth_ref":  [
                    "r285",
                    "r287"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Due in Two Years",
                            "terseLabel":  "Second year",
                            "verboseLabel":  "2021"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Operating Leases, Future Minimum Payments, Remainder of Fiscal Year",
                            "terseLabel":  "First year",
                            "verboseLabel":  "2020"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The percentage points added to the reference rate to compute the variable rate on the lessee's operating lease.",
                            "label":  "Operating Leases of Lessee, Contingent Rentals, Basis Spread on Variable Rate"
                            }
                        }
                    },
                "localname":  "OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_OperatingLeasesRentExpenseMinimumRentals":  {
                "auth_ref":  [
                    "r284",
                    "r285",
                    "r286"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.",
                            "label":  "Operating Leases, Rent Expense, Minimum Rentals"
                            }
                        }
                    },
                "localname":  "OperatingLeasesRentExpenseMinimumRentals",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLossCarryforwards":  {
                "auth_ref":  [
                    "r253"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
                            "label":  "Operating Loss Carryforwards"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OptionIndexedToIssuersEquityTypeAxis":  {
                "auth_ref":  [
                    "r154",
                    "r270",
                    "r271",
                    "r272"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.",
                            "label":  "Option Indexed to Issuer's Equity, Type [Axis]"
                            }
                        }
                    },
                "localname":  "OptionIndexedToIssuersEquityTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OptionIndexedToIssuersEquityTypeDomain":  {
                "auth_ref":  [
                    "r273"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock.  Specifically, the pertinent rights and privileges of the securities outstanding.",
                            "label":  "Option Indexed To Issuers Equity Type [Domain]",
                            "terseLabel":  "Option Indexed to Issuer's Equity, Type [Domain]"
                            }
                        }
                    },
                "localname":  "OptionIndexedToIssuersEquityTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "GENERAL ORGANIZATION AND BUSINESS"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherAccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r6",
                    "r7",
                    "r8",
                    "r37"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
                            "label":  "Other Accrued Liabilities, Current",
                            "terseLabel":  "Accrued other"
                            }
                        }
                    },
                "localname":  "OtherAccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssetsNoncurrent":  {
                "auth_ref":  [
                    "r34"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of noncurrent assets classified as other.",
                            "label":  "Other Assets, Noncurrent",
                            "verboseLabel":  "Long-term assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
                            "terseLabel":  "Other comprehensive gain (loss):"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax":  {
                "auth_ref":  [
                    "r48",
                    "r50"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.",
                            "label":  "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax",
                            "terseLabel":  "Unrealized loss on short-term investments",
                            "verboseLabel":  "Net unrealized gain (loss) on short-term investments"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherIncomeMember":  {
                "auth_ref":  [
                    "r269"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing other revenue.",
                            "label":  "Other Income [Member]",
                            "terseLabel":  "Other Income"
                            }
                        }
                    },
                "localname":  "OtherIncomeMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherLiabilitiesNoncurrent":  {
                "auth_ref":  [
                    "r40"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
                            "label":  "Other Liabilities, Noncurrent",
                            "terseLabel":  "Other liabilities"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OverAllotmentOptionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Right given to the underwriter to sell additional shares over the initial allotment.",
                            "label":  "Over Allotment Option [Member]",
                            "terseLabel":  "Underwriter"
                            }
                        }
                    },
                "localname":  "OverAllotmentOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation":  {
                "auth_ref":  [
                    "r71"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
                            "label":  "Payments Related to Tax Withholding for Share-based Compensation",
                            "negatedLabel":  "Tax payments related to shares withheld for vested restricted stock awards"
                            }
                        }
                    },
                "localname":  "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireAvailableForSaleSecurities":  {
                "auth_ref":  [
                    "r67",
                    "r117"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.",
                            "label":  "Payments to Acquire Available-for-sale Securities",
                            "negatedLabel":  "Purchase of short-term investments"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireAvailableForSaleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r68"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
                            "label":  "Payments to Acquire Property, Plant, and Equipment",
                            "negatedLabel":  "Purchase of property and equipment"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquirePropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PlanNameAxis":  {
                "auth_ref":  [
                    "r183",
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Axis]"
                            }
                        }
                    },
                "localname":  "PlanNameAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PlanNameDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Domain]",
                            "terseLabel":  "Plan Name [Domain]"
                            }
                        }
                    },
                "localname":  "PlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PreferredStockLiquidationPreferenceValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
                            "label":  "Preferred Stock, Liquidation Preference, Value"
                            }
                        }
                    },
                "localname":  "PreferredStockLiquidationPreferenceValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
                            "label":  "Preferred Stock, Par or Stated Value Per Share",
                            "verboseLabel":  "Preferred stock, par or stated value per share"
                            }
                        }
                    },
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred Stock, Shares Authorized",
                            "terseLabel":  "Preferred stock, shares authorized"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesIssued":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury).  May be all or portion of the number of preferred shares authorized.  Excludes preferred shares that are classified as debt.",
                            "label":  "Preferred Stock, Shares Issued"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased.",
                            "label":  "Preferred Stock, Shares Outstanding",
                            "verboseLabel":  "Preferred stock, shares outstanding"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockValue":  {
                "auth_ref":  [
                    "r21"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Preferred Stock, Value, Issued",
                            "terseLabel":  "Preferred stock, Value"
                            }
                        }
                    },
                "localname":  "PreferredStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsCurrent":  {
                "auth_ref":  [
                    "r3",
                    "r28",
                    "r29"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Expense and Other Assets, Current",
                            "verboseLabel":  "Prepaid expenses and other assets"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseAndOtherAssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrepaidExpenseCurrent":  {
                "auth_ref":  [
                    "r2",
                    "r4",
                    "r129"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Expense, Current",
                            "terseLabel":  "Prepaid expense, current"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrivatePlacementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
                            "label":  "Private Placement [Member]",
                            "terseLabel":  "Private Placement"
                            }
                        }
                    },
                "localname":  "PrivatePlacementMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "auth_ref":  [
                    "r69"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash inflow from the additional capital contribution to the entity.",
                            "label":  "Proceeds from Issuance of Common Stock",
                            "verboseLabel":  "Proceeds from the issuance of common stock, net"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromRelatedPartyDebt":  {
                "auth_ref":  [
                    "r70"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.  Alternate caption:  Proceeds from Advances from Affiliates.",
                            "label":  "Proceeds from Related Party Debt",
                            "terseLabel":  "Proceeds from related party debt"
                            }
                        }
                    },
                "localname":  "ProceedsFromRelatedPartyDebt",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities":  {
                "auth_ref":  [
                    "r65",
                    "r66",
                    "r117"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
                            "label":  "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
                            "verboseLabel":  "Maturities of short-term investments"
                            }
                        }
                    },
                "localname":  "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromStockOptionsExercised":  {
                "auth_ref":  [
                    "r69",
                    "r216"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from exercise of option under share-based payment arrangement.",
                            "label":  "Proceeds from Stock Options Exercised",
                            "verboseLabel":  "Proceeds from the issuance of common stock upon exercise of options"
                            }
                        }
                    },
                "localname":  "ProceedsFromStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromWarrantExercises":  {
                "auth_ref":  [
                    "r69"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash inflow associated with the amount received from holders exercising their stock warrants.",
                            "label":  "Proceeds from Warrant Exercises",
                            "verboseLabel":  "Proceeds from the issuance of common stock upon exercise of warrants"
                            }
                        }
                    },
                "localname":  "ProceedsFromWarrantExercises",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "BALANCE SHEET COMPONENTS"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "auth_ref":  [
                    "r33",
                    "r141"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
                            "label":  "Property, Plant and Equipment, Type [Axis]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives":  {
                "auth_ref":  [
                    "r83",
                    "r135"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
                            "label":  "Property, Plant and Equipment, Estimated Useful Lives"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentEstimatedUsefulLives",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentGross":  {
                "auth_ref":  [
                    "r32",
                    "r139"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Gross",
                            "verboseLabel":  "Total Property and equipment, cost"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentGross",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "auth_ref":  [
                    "r13",
                    "r14",
                    "r141",
                    "r333"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Net",
                            "totalLabel":  "Property and equipment, net",
                            "verboseLabel":  "Property and equipment, net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock":  {
                "auth_ref":  [
                    "r31",
                    "r83",
                    "r141"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.",
                            "label":  "Property, Plant and Equipment, Policy [Policy Text Block]",
                            "verboseLabel":  "Property and Equipment, net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTextBlock":  {
                "auth_ref":  [
                    "r13",
                    "r141"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table Text Block]",
                            "verboseLabel":  "Schedule of Property, Plant and Equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "auth_ref":  [
                    "r13",
                    "r139"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
                            "label":  "Property Plant And Equipment Type [Domain]",
                            "terseLabel":  "Property, Plant and Equipment, Type [Domain]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentUsefulLife":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.  Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
                            "label":  "Property, Plant and Equipment, Useful Life"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentUsefulLife",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_QuarterlyFinancialInformationDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "QUARTERLY UNAUDITED RESULTS"
                            }
                        }
                    },
                "localname":  "QuarterlyFinancialInformationDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_QuarterlyFinancialInformationTextBlock":  {
                "auth_ref":  [
                    "r101"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for quarterly financial data.  Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
                            "label":  "Quarterly Financial Information [Text Block]",
                            "terseLabel":  "QUARTERLY UNAUDITED RESULTS"
                            }
                        }
                    },
                "localname":  "QuarterlyFinancialInformationTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureQuarterlyUnauditedResults"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RelatedPartyTransactionAxis":  {
                "auth_ref":  [
                    "r176",
                    "r308",
                    "r310"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of related party transaction.",
                            "label":  "Related Party Transaction [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Transaction between related party.",
                            "label":  "Related Party Transaction [Domain]",
                            "terseLabel":  "Related Party Transaction [Domain]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "RELATED PARTY TRANSACTIONS"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r311"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Related Party Transactions Disclosure [Text Block]",
                            "terseLabel":  "RELATED PARTY TRANSACTIONS"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactions"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross":  {
                "auth_ref":  [
                    "r229",
                    "r230"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others.",
                            "label":  "Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross",
                            "terseLabel":  "Research and development arrangement, contract to perform for others, costs incurred, gross"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpense":  {
                "auth_ref":  [
                    "r228",
                    "r337"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
                            "label":  "Research and Development Expense",
                            "verboseLabel":  "Research and development expenses"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpenseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption in which the reported facts about research and development expense have been included.",
                            "label":  "Research And Development Expense [Member]",
                            "terseLabel":  "Research and development"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationExpenseDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpensePolicy":  {
                "auth_ref":  [
                    "r83",
                    "r228"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
                            "label":  "Research and Development Expense, Policy [Policy Text Block]",
                            "verboseLabel":  "Research and Development Expenses"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpensePolicy",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RestrictedCash":  {
                "auth_ref":  [
                    "r82",
                    "r318",
                    "r330"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                        "weight":  1.0
                        },
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash restricted as to withdrawal or usage.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
                            "label":  "Restricted Cash",
                            "terseLabel":  "Restricted cash",
                            "verboseLabel":  "Restricted cash (included in non-current assets on the consolidated balance sheets)"
                            }
                        }
                    },
                "localname":  "RestrictedCash",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureGeneralOrganizationAndBusinessDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Type of cash and cash equivalent.  Cash is currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]",
                            "terseLabel":  "Cash and Cash Equivalents [Domain]"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RestrictedStockMember":  {
                "auth_ref":  [
                    "r97"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
                            "label":  "Restricted Stock [Member]",
                            "terseLabel":  "Restricted stock award expenses"
                            }
                        }
                    },
                "localname":  "RestrictedStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationByInstrumentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RestrictedStockUnitsRSUMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
                            "label":  "Restricted Stock Units R S U [Member]",
                            "terseLabel":  "Restricted stock units"
                            }
                        }
                    },
                "localname":  "RestrictedStockUnitsRSUMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationByInstrumentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r24",
                    "r167",
                    "r331"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings (Accumulated Deficit)",
                            "verboseLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]",
                            "terseLabel":  "Accumulated Deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SaleOfStockNameOfTransactionDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
                            "label":  "Sale Of Stock Name Of Transaction [Domain]",
                            "terseLabel":  "Sale of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "SaleOfStockNameOfTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SaleOfStockPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
                            "label":  "Sale of Stock, Price Per Share",
                            "terseLabel":  "Sale of stock, price per share"
                            }
                        }
                    },
                "localname":  "SaleOfStockPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of accrued liabilities.",
                            "label":  "Schedule of Accrued Liabilities [Table Text Block]",
                            "verboseLabel":  "Schedule of accrued liabilities"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccruedLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock":  {
                "auth_ref":  [
                    "r97"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
                            "verboseLabel":  "Schedule of Antidilutive securities excluded from computation of earnings per share"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of cash, cash equivalents, and investments.",
                            "label":  "Cash, Cash Equivalents and Investments [Table Text Block]",
                            "verboseLabel":  "Schedule of cash, money market funds and short-term investments"
                            }
                        }
                    },
                "localname":  "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock":  {
                "auth_ref":  [
                    "r212"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan.  Includes, but is not limited to, related tax benefit.",
                            "label":  "Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]",
                            "verboseLabel":  "Schedule of compensation cost for share-based payment arrangements, allocation of share-based compensation costs by plan"
                            }
                        }
                    },
                "localname":  "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock":  {
                "auth_ref":  [
                    "r258"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
                            "label":  "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
                            "verboseLabel":  "Schedule of Components of Income Tax Expense (Benefit)"
                            }
                        }
                    },
                "localname":  "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    "r251"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
                            "label":  "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
                            "verboseLabel":  "Schedule of Deferred Tax Assets and Liabilities"
                            }
                        }
                    },
                "localname":  "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock":  {
                "auth_ref":  [
                    "r237"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
                            "label":  "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
                            "verboseLabel":  "Schedule of Effective Income Tax Rate Reconciliation"
                            }
                        }
                    },
                "localname":  "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock":  {
                "auth_ref":  [
                    "r182",
                    "r212",
                    "r223"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position.  Includes, but is not limited to, corresponding line item in financial statement.",
                            "label":  "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]",
                            "verboseLabel":  "Schedule of stock-based compensation"
                            }
                        }
                    },
                "localname":  "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock":  {
                "auth_ref":  [
                    "r288"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
                            "label":  "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
                            "terseLabel":  "Schedule of maturities of the Company's operating lease liabilities"
                            }
                        }
                    },
                "localname":  "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock":  {
                "auth_ref":  [
                    "r100"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of quarterly financial data.  Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
                            "label":  "Quarterly Financial Information [Table Text Block]",
                            "verboseLabel":  "Schedule of Quarterly Financial Information"
                            }
                        }
                    },
                "localname":  "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureQuarterlyUnauditedResultsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable":  {
                "auth_ref":  [
                    "r183",
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of information about share-based payment arrangement.",
                            "label":  "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable":  {
                "auth_ref":  [
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
                            "label":  "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock":  {
                "auth_ref":  [
                    "r189",
                    "r199",
                    "r202"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure for stock option plans.  Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
                            "label":  "Share-based Compensation, Stock Options, Activity [Table Text Block]",
                            "verboseLabel":  "Schedule of status of stock options"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock":  {
                "auth_ref":  [
                    "r206"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
                            "label":  "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
                            "verboseLabel":  "Schedule of share-based payment award, stock options, valuation assumptions"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "auth_ref":  [
                    "r41",
                    "r86",
                    "r155",
                    "r157",
                    "r158",
                    "r160",
                    "r161",
                    "r162",
                    "r164",
                    "r165",
                    "r166",
                    "r167"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
                            "label":  "Schedule of Stock by Class [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock":  {
                "auth_ref":  [
                    "r85",
                    "r169",
                    "r181"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of warrants or rights issued.  Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame.  Warrants are often included in a new debt issue to entice investors by a higher return potential.  The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company.  Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.  Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
                            "label":  "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
                            "terseLabel":  "Schedule of Stockholders' Equity Note, Warrants or Rights"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock":  {
                "auth_ref":  [
                    "r245",
                    "r259"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the change in unrecognized tax benefits.",
                            "label":  "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
                            "verboseLabel":  "Schedule of Unrecognized Tax Benefits"
                            }
                        }
                    },
                "localname":  "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SecurityDeposit":  {
                "auth_ref":  [
                    "r45"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
                            "label":  "Security Deposit",
                            "terseLabel":  "Security deposit"
                            }
                        }
                    },
                "localname":  "SecurityDeposit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesCashCashEquivalentsAndRestrictedCashDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SegmentReportingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    "r83"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for segment reporting.",
                            "label":  "Segment Reporting, Policy [Policy Text Block]",
                            "verboseLabel":  "Segment reporting"
                            }
                        }
                    },
                "localname":  "SegmentReportingPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock":  {
                "auth_ref":  [
                    "r83",
                    "r227"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
                            "label":  "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
                            "verboseLabel":  "General and Administrative Expenses"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SeriesAPreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock.  Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer.  Classified within temporary equity if redemption is outside the control of the issuer.",
                            "label":  "Series A Preferred Stock [Member]",
                            "terseLabel":  "Series A Convertible Preferred Stock"
                            }
                        }
                    },
                "localname":  "SeriesAPreferredStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SeriesBPreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock.  Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer.  Classified within temporary equity if redemption is outside the control of the issuer.",
                            "label":  "Series B Preferred Stock [Member]",
                            "terseLabel":  "Series B Convertible Preferred Stock"
                            }
                        }
                    },
                "localname":  "SeriesBPreferredStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensation":  {
                "auth_ref":  [
                    "r74"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for share-based payment arrangement.",
                            "label":  "Share-based Compensation",
                            "terseLabel":  "Stock-based compensation expense",
                            "verboseLabel":  "Share-based Compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1":  {
                "auth_ref":  [
                    "r185"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.  Includes, but is not limited to, combination of market, performance or service condition.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
                            "terseLabel":  "Vesting period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r197"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
                            "verboseLabel":  "Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r197"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
                            "verboseLabel":  "Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":  {
                "auth_ref":  [
                    "r196"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
                            "terseLabel":  "Unvested shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":  {
                "auth_ref":  [
                    "r198"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
                            "negatedLabel":  "Vested"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":  {
                "auth_ref":  [
                    "r209"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
                            "verboseLabel":  "Expected dividend yield"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":  {
                "auth_ref":  [
                    "r208"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The estimated measure of the percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
                            "verboseLabel":  "Expected volatility"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":  {
                "auth_ref":  [
                    "r210"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
                            "verboseLabel":  "Risk-free interest rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
                            "terseLabel":  "STOCK BASED COMPENSATION"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized":  {
                "auth_ref":  [
                    "r186"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares authorized for issuance under share-based payment arrangement.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
                            "terseLabel":  "Shares authorized"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant":  {
                "auth_ref":  [
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
                            "terseLabel":  "Number of shares available"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
                            "verboseLabel":  "Weighted Average Exercise Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":  {
                "auth_ref":  [
                    "r192"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
                            "terseLabel":  "Options exercisable, number"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r192"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
                            "terseLabel":  "Options exercisable, exercise price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue":  {
                "auth_ref":  [
                    "r201"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
                            "terseLabel":  "Intrinsic value of options exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod":  {
                "auth_ref":  [
                    "r195"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
                            "negatedTerseLabel":  "Expired/Forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod":  {
                "auth_ref":  [
                    "r194"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
                            "negatedLabel":  "Expired/Cancelled"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r194"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average price of options that were either forfeited or expired.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Expired/Forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Gross number of share options (or share units) granted during the period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
                            "terseLabel":  "Issued",
                            "verboseLabel":  "Issued"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r200"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Weighted average grant date fair value, options granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "auth_ref":  [
                    "r191",
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of options outstanding, including both vested and non-vested options.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
                            "periodEndLabel":  "Outstanding, ending balance",
                            "periodStartLabel":  "Outstanding, beginning balance",
                            "terseLabel":  "Options outstanding, number"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
                            "terseLabel":  "Shares Under Warrants",
                            "verboseLabel":  "Number of Options"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r190"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
                            "periodEndLabel":  "Outstanding, ending balance",
                            "periodStartLabel":  "Outstanding, beginning balance",
                            "terseLabel":  "Options outstanding, exercise price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue":  {
                "auth_ref":  [
                    "r204"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options.  Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
                            "terseLabel":  "Exercisable"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue":  {
                "auth_ref":  [
                    "r202"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding.  Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
                            "periodEndLabel":  "Outstanding, ending balance",
                            "terseLabel":  "Outstanding, end of period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock":  {
                "auth_ref":  [
                    "r202"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest.  Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]",
                            "verboseLabel":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward":  {
                "auth_ref":  [
                    "r184"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Description of terms of award under share-based payment arrangement.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "auth_ref":  [
                    "r181",
                    "r187"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Award under share-based payment arrangement.",
                            "label":  "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
                            "terseLabel":  "Equity Award [Domain]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationByInstrumentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
                            "label":  "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Exercised",
                            "verboseLabel":  "Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
                            "label":  "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Expired/Cancelled"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
                            "label":  "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Exercise price (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationAwardTrancheOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
                            "label":  "Share Based Compensation Award Tranche One [Member]",
                            "terseLabel":  "Vesting on first anniversary"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationAwardTrancheOneMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationAwardTrancheThreeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
                            "label":  "Share Based Compensation Award Tranche Three [Member]",
                            "terseLabel":  "Vesting on satisfaction of clinical trial milestones"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationAwardTrancheThreeMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationAwardTrancheTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
                            "label":  "Share Based Compensation Award Tranche Two [Member]",
                            "terseLabel":  "Vesting over period after first anniversary"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationAwardTrancheTwoMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy":  {
                "auth_ref":  [
                    "r83",
                    "r183",
                    "r188"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for award under share-based payment arrangement.  Includes, but is not limited to, methodology and assumption used in measuring cost.",
                            "label":  "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]",
                            "verboseLabel":  "Stock-Based Compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationOptionAndIncentivePlansPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":  {
                "auth_ref":  [
                    "r205"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by range of option prices pertaining to options granted.",
                            "label":  "Exercise Price Range [Axis]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain":  {
                "auth_ref":  [
                    "r211"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
                            "label":  "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain]",
                            "terseLabel":  "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit":  {
                "auth_ref":  [
                    "r211"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
                            "label":  "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit",
                            "terseLabel":  "Options exercise price, lower limit"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit":  {
                "auth_ref":  [
                    "r211"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
                            "label":  "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit",
                            "terseLabel":  "Options exercise price, upper limit"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1":  {
                "auth_ref":  [
                    "r212"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost",
                            "terseLabel":  "Total stock-based compensation expenses"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationByInstrumentDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1":  {
                "auth_ref":  [
                    "r207",
                    "r222"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
                            "verboseLabel":  "Expected term (years)"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Options exercisable, remaining term"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r203"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Options outstanding, remaining term"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationExercisePriceDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury.",
                            "label":  "Shares, Outstanding",
                            "periodEndLabel":  "Ending Balance (in Shares)",
                            "periodStartLabel":  "Beginning Balance (in Shares)"
                            }
                        }
                    },
                "localname":  "SharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShortTermInvestments":  {
                "auth_ref":  [
                    "r15",
                    "r321",
                    "r322",
                    "r324",
                    "r328"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
                            "label":  "Short-term Investments",
                            "verboseLabel":  "Short-term investments"
                            }
                        }
                    },
                "localname":  "ShortTermInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureGeneralOrganizationAndBusinessDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShortTermLeaseCost":  {
                "auth_ref":  [
                    "r300",
                    "r306"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LeaseCost",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
                            "label":  "Short-term Lease, Cost",
                            "verboseLabel":  "Short-term lease cost"
                            }
                        }
                    },
                "localname":  "ShortTermLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r89"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "Significant Accounting Policies [Text Block]",
                            "verboseLabel":  "SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPractices"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]",
                            "verboseLabel":  "State and Local"
                            }
                        }
                    },
                "localname":  "StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesExpenseComponentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StateAndLocalJurisdictionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
                            "label":  "State And Local Jurisdiction [Member]",
                            "terseLabel":  "State and Local Jurisdiction [Member]"
                            }
                        }
                    },
                "localname":  "StateAndLocalJurisdictionMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r22",
                    "r159"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by the different classes of stock of the entity.",
                            "label":  "Class of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "StatementClassOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r44",
                    "r159"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails",
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationByInstrumentDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationExpenseDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Condensed Consolidated Statements of Cash Flows"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Condensed Consolidated Balance Sheets"
                            }
                        }
                    },
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Condensed Consolidated Statements of Comprehensive Loss"
                            }
                        }
                    },
                "localname":  "StatementOfIncomeAndComprehensiveIncomeAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails",
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureLicensesAndAgreementsDetails",
                    "http://lbio.com/role/DisclosureRelatedPartyTransactionsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationByInstrumentDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesStockBasedCompensationExpenseDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesUsefulLivesImpairmentDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities":  {
                "auth_ref":  [
                    "r43",
                    "r159",
                    "r160",
                    "r167"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period as a result of the conversion of convertible securities.",
                            "label":  "Stock Issued During Period, Shares, Conversion of Convertible Securities",
                            "verboseLabel":  "Conversion of convertible preferred stock into common stock (in Shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r159",
                    "r167"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of new stock issued during the period.",
                            "label":  "Stock Issued During Period, Shares, New Issues",
                            "verboseLabel":  "Common stock sold in public offering, net of offering costs (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r159",
                    "r167"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
                            "label":  "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
                            "verboseLabel":  "Vesting of restricted shares issued for services (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r159",
                    "r167",
                    "r193"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
                            "negatedLabel":  "Exercised",
                            "verboseLabel":  "Common stock issued upon exercise of stock options (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities":  {
                "auth_ref":  [
                    "r44",
                    "r159",
                    "r167"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The gross value of stock issued during the period upon the conversion of convertible securities.",
                            "label":  "Stock Issued During Period, Value, Conversion of Convertible Securities",
                            "verboseLabel":  "Conversion of convertible preferred stock into common stock"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r159",
                    "r167"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering.",
                            "label":  "Stock Issued During Period, Value, New Issues",
                            "verboseLabel":  "Common stock sold in public offering, net of offering costs"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures":  {
                "auth_ref":  [
                    "r159",
                    "r167"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
                            "label":  "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
                            "verboseLabel":  "Vesting of restricted shares issued for services"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised":  {
                "auth_ref":  [
                    "r44",
                    "r159",
                    "r167"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Value of stock issued as a result of the exercise of stock options.",
                            "label":  "Stock Issued During Period, Value, Stock Options Exercised",
                            "verboseLabel":  "Common stock issued upon exercise of stock options"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r159",
                    "r167"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares that have been repurchased and retired during the period.",
                            "label":  "Stock Repurchased and Retired During Period, Shares",
                            "terseLabel":  "Stock repurchased (in shares)"
                            }
                        }
                    },
                "localname":  "StockRepurchasedAndRetiredDuringPeriodShares",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r22",
                    "r25",
                    "r26",
                    "r116"
                    ],
                "calculation":  {
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "periodEndLabel":  "Ending Balance",
                            "periodStartLabel":  "Beginning Balance",
                            "totalLabel":  "Total Stockholders' Equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Condensed Consolidated Statements of Stockholders' Equity",
                            "verboseLabel":  "Stockholders' Equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityNoteAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "STOCKHOLDERS' EQUITY"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "auth_ref":  [
                    "r170"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income.  Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
                            "label":  "Stockholders' Equity Note Disclosure [Text Block]",
                            "verboseLabel":  "STOCKHOLDERS' EQUITY"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquity"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy":  {
                "auth_ref":  [
                    "r18",
                    "r19",
                    "r83",
                    "r156"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for redeemable preferred stock issued.  This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount.  For example, describe whether the issuer accretes changes in the redemption value.",
                            "label":  "Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]",
                            "verboseLabel":  "Preferred Stock"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteRedeemablePreferredStockIssuePolicy",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1":  {
                "auth_ref":  [
                    "r168"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
                            "label":  "Stockholders' Equity Note, Stock Split, Conversion Ratio"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteStockSplitConversionRatio1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "us-gaap_SubsequentEventsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    "r83"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for reporting subsequent events.",
                            "label":  "Subsequent Events, Policy [Policy Text Block]",
                            "verboseLabel":  "Subsequent Events"
                            }
                        }
                    },
                "localname":  "SubsequentEventsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsidiarySaleOfStockAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of sale of the entity's stock.",
                            "label":  "Sale of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "SubsidiarySaleOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock":  {
                "auth_ref":  [
                    "r47"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
                            "label":  "Supplemental Balance Sheet Disclosures [Text Block]",
                            "terseLabel":  "BALANCE SHEET COMPONENTS"
                            }
                        }
                    },
                "localname":  "SupplementalBalanceSheetDisclosuresTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureBalanceSheetComponents"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain":  {
                "auth_ref":  [
                    "r316"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
                            "label":  "Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]",
                            "terseLabel":  "Financial Instruments [Domain]"
                            }
                        }
                    },
                "localname":  "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TypeOfAdoptionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States.  The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009.  As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right.  All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification.  For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.",
                            "label":  "Type Of Adoption [Member]",
                            "terseLabel":  "Type of Adoption [Domain]"
                            }
                        }
                    },
                "localname":  "TypeOfAdoptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesAdditionalInformationDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesConcentrationsEtcDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember":  {
                "auth_ref":  [
                    "r325"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This category includes information about debt issued by US Government Corporations and Agencies.  Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
                            "label":  "U S Government Corporations And Agencies Securities [Member]",
                            "terseLabel":  "US government agency securities"
                            }
                        }
                    },
                "localname":  "USGovernmentCorporationsAndAgenciesSecuritiesMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_USTreasurySecuritiesMember":  {
                "auth_ref":  [
                    "r174",
                    "r177",
                    "r323"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government.  Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
                            "label":  "U S Treasury Securities [Member]",
                            "terseLabel":  "US treasury securities"
                            }
                        }
                    },
                "localname":  "USTreasurySecuritiesMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails",
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsShortTermInvestmentsDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesFairValueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of unrealized gains and losses on investments.",
                            "label":  "Unrealized Gain (Loss) on Investments [Table Text Block]",
                            "verboseLabel":  "Schedule of cost and fair value of cash equivalents and short-term investments"
                            }
                        }
                    },
                "localname":  "UnrealizedGainLossOnInvestmentsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureCashAndCashEquivalentsAndShortTermInvestmentsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_UnrecognizedTaxBenefits":  {
                "auth_ref":  [
                    "r233",
                    "r242"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of unrecognized tax benefits.",
                            "label":  "Unrecognized Tax Benefits",
                            "periodEndLabel":  "Unrecognized benefit-end of period",
                            "periodStartLabel":  "Unrecognized benefit-beginning of period"
                            }
                        }
                    },
                "localname":  "UnrecognizedTaxBenefits",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesUnrecognizedBenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions":  {
                "auth_ref":  [
                    "r243"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
                            "label":  "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
                            "verboseLabel":  "Gross decreases-prior period tax positions"
                            }
                        }
                    },
                "localname":  "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesUnrecognizedBenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions":  {
                "auth_ref":  [
                    "r244"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
                            "label":  "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
                            "verboseLabel":  "Gross increases-current period tax positions"
                            }
                        }
                    },
                "localname":  "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesUnrecognizedBenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r102",
                    "r103",
                    "r105",
                    "r106",
                    "r107",
                    "r108",
                    "r109"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use of Estimates, Policy [Policy Text Block]",
                            "verboseLabel":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount":  {
                "auth_ref":  [
                    "r234"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
                            "label":  "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount"
                            }
                        }
                    },
                "localname":  "ValuationAllowanceDeferredTaxAssetChangeInAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureIncomeTaxesOtherInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_VariableLeaseCost":  {
                "auth_ref":  [
                    "r301",
                    "r306"
                    ],
                "calculation":  {
                    "http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LeaseCost",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
                            "label":  "Variable Lease, Cost",
                            "verboseLabel":  "Variable lease cost"
                            }
                        }
                    },
                "localname":  "VariableLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_VestingAxis":  {
                "auth_ref":  [
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by vesting schedule of award under share-based payment arrangement.",
                            "label":  "Vesting [Axis]"
                            }
                        }
                    },
                "localname":  "VestingAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_VestingDomain":  {
                "auth_ref":  [
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Vesting schedule of award under share-based payment arrangement.",
                            "label":  "Vesting [Domain]",
                            "terseLabel":  "Vesting [Domain]"
                            }
                        }
                    },
                "localname":  "VestingDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_WarrantMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
                            "label":  "Warrant [Member]",
                            "terseLabel":  "Warrant"
                            }
                        }
                    },
                "localname":  "WarrantMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureLegalProceedingsDetails",
                    "http://lbio.com/role/DisclosureStockholdersEquityWarrantActivityDetails",
                    "http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPracticesLossPerShareDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
                            "label":  "Weighted Average Number of Shares Outstanding, Basic and Diluted",
                            "terseLabel":  "Weighted average share used in computing net loss per share, basic and diluted",
                            "verboseLabel":  "Weighted Average Common Shares Outstanding, Basic and Diluted"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://lbio.com/role/DisclosureQuarterlyUnauditedResultsDetails",
                    "http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "sharesItemType"
                }
            },
        "unitCount":  7
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/topic&trid=2122149"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 201.5-02(25))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "270",
        "URI":  "http://asc.fasb.org/extlink&oid=118952077&loc=d3e1280-108306"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "270",
        "URI":  "http://asc.fasb.org/topic&trid=2126967"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 201.5-02(26))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/topic&trid=2134479"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4647-111522"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "320",
        "URI":  "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "320",
        "URI":  "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "320",
        "URI":  "http://asc.fasb.org/topic&trid=2196928"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(13))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(1)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(14))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(2))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/subtopic&trid=2127163"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "30",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/subtopic&trid=2127197"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "460",
        "URI":  "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "63",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "480",
        "URI":  "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(CFRR 211.02)",
        "Topic":  "480",
        "URI":  "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=116854557&loc=d3e20905-112640"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(22))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 4.C)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "50",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(23))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/topic&trid=2208762"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "710",
        "URI":  "http://asc.fasb.org/topic&trid=2127225"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "712",
        "URI":  "http://asc.fasb.org/topic&trid=2197446"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(ii)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(01)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(n)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "70",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/topic&trid=2235017"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a),(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b),(f)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27)(c))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)-(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(3)-(4)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(4)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(i)-(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iv)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116863282&loc=SL116876444-165333"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116863282&loc=SL116876444-165333"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116863282&loc=SL116876444-165333"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116863282&loc=SL116876446-165333"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116863282&loc=SL116876446-165333"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.D.2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.F)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/topic&trid=2228938"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "35",
        "Subparagraph":  "(a)",
        "Topic":  "720",
        "URI":  "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "730",
        "URI":  "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "730",
        "URI":  "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "730",
        "URI":  "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b),(c)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "217",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.7)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "30",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/topic&trid=2144680"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c),(3)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3A-02)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3A-03)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624186-113959"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=6445032&loc=d3e90193-114008"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=6445032&loc=d3e90198-114008"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=6445032&loc=d3e90205-114008"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=116862287&loc=d3e90476-114009"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(1)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(2)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(7))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=77910348&loc=d3e34039-112682"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(Note 3)",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41499-112717"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(8))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(j)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(3)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.1)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(1)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(3)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(4)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "53",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/subtopic&trid=77888251"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.13(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/topic&trid=2122745"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "340",
        "Topic":  "928",
        "URI":  "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(1)(a))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.13)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(4))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(5))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(6)(a)(1))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(6))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.6(a)(1))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "825",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(1)(g))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.14)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(2))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "740",
        "Topic":  "954",
        "URI":  "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "220",
        "Subparagraph":  "(a)",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=114873921&loc=SL114875236-224282"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "985",
        "URI":  "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
        },
    "r338":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r339":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.17)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r340":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1-"
        },
    "r341":  {
        "Name":  "Forms 10-K, 20-F, 40-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "15",
        "Subsection":  "d-1"
        },
    "r342":  {
        "Name":  "Regulation 12B",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r343":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19-26)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(5))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.24)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.28,29)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-30)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.8,17)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.9)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/topic&trid=2122208"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(4))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.7(b))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.8)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3151-108585"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a),(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(i))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(d),(e))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(h)(2))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(m)(1)(i)(A))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/topic&trid=2122369"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 201.5-02(24))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
        }
    },
"version":  "2.1"
}

10 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Iovance Biotherapeutics, Inc.     10-K       12/31/23   95:11M                                    Toppan Merrill Bridge/FA
 6/12/23  Iovance Biotherapeutics, Inc.     S-8         6/12/23    7:210K                                   Toppan Merrill/FA
 2/28/23  Iovance Biotherapeutics, Inc.     10-K       12/31/22   78:10M                                    Toppan Merrill Bridge/FA
11/18/22  Iovance Biotherapeutics, Inc.     424B5                  2:804K                                   Toppan Merrill/FA
 8/04/22  Iovance Biotherapeutics, Inc.     S-8         8/04/22    5:62K                                    Toppan Merrill/FA
 2/24/22  Iovance Biotherapeutics, Inc.     10-K       12/31/21   79:10M                                    Toppan Merrill Bridge/FA
 2/25/21  Iovance Biotherapeutics, Inc.     10-K       12/31/20   84:11M                                    Toppan Merrill Bridge/FA
 2/09/21  Iovance Biotherapeutics, Inc.     424B5                  1:799K                                   Toppan Merrill/FA
11/05/20  Iovance Biotherapeutics, Inc.     10-Q        9/30/20   62:7.8M                                   Toppan Merrill Bridge/FA
 8/06/20  Iovance Biotherapeutics, Inc.     10-Q        6/30/20   63:7.7M                                   Toppan Merrill/FA

↑Top

Filing Submission 0001104659-20-024830 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Iovance Biotherapeutics, Inc. – ‘10-K’ for 12/31/19 – ‘JSON’

On: Tuesday, 2/25/20, at 5:11pm ET · For: 12/31/19 · Accession #: 1104659-20-24830 · File #: 1-36860

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

10 Subsequent Filings that Reference this Filing

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents